CA2253549C - Device for enhancing transdermal agent delivery or sampling - Google Patents

Device for enhancing transdermal agent delivery or sampling Download PDF

Info

Publication number
CA2253549C
CA2253549C CA002253549A CA2253549A CA2253549C CA 2253549 C CA2253549 C CA 2253549C CA 002253549 A CA002253549 A CA 002253549A CA 2253549 A CA2253549 A CA 2253549A CA 2253549 C CA2253549 C CA 2253549C
Authority
CA
Canada
Prior art keywords
blades
sheet
agent
openings
blade
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002253549A
Other languages
French (fr)
Other versions
CA2253549A1 (en
Inventor
Michel J.N. Cormier
Armand P. Neukermans
Barry Block
Felix T. Theeuwes
Alfred A. Amkraut
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of CA2253549A1 publication Critical patent/CA2253549A1/en
Application granted granted Critical
Publication of CA2253549C publication Critical patent/CA2253549C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14507Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
    • A61B5/1451Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
    • A61B5/14514Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150015Source of blood
    • A61B5/150022Source of blood for capillary blood or interstitial fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150053Details for enhanced collection of blood or interstitial fluid at the sample site, e.g. by applying compression, heat, vibration, ultrasound, suction or vacuum to tissue; for reduction of pain or discomfort; Skin piercing elements, e.g. blades, needles, lancets or canulas, with adjustable piercing speed
    • A61B5/150061Means for enhancing collection
    • A61B5/150099Means for enhancing collection by negative pressure, other than vacuum extraction into a syringe by pulling on the piston rod or into pre-evacuated tubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150206Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150274Manufacture or production processes or steps for blood sampling devices
    • A61B5/150282Manufacture or production processes or steps for blood sampling devices for piercing elements, e.g. blade, lancet, canula, needle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150412Pointed piercing elements, e.g. needles, lancets for piercing the skin
    • A61B5/150427Specific tip design, e.g. for improved penetration characteristics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150969Low-profile devices which resemble patches or plasters, e.g. also allowing collection of blood samples for testing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150977Arrays of piercing elements for simultaneous piercing
    • A61B5/150984Microneedles or microblades
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15103Piercing procedure
    • A61B5/15105Purely manual piercing, i.e. the user pierces the skin without the assistance of any driving means or driving devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15103Piercing procedure
    • A61B5/15107Piercing being assisted by a triggering mechanism
    • A61B5/15113Manually triggered, i.e. the triggering requires a deliberate action by the user such as pressing a drive button
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15142Devices intended for single use, i.e. disposable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/20Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/20Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303Constructional details
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045Devices for taking samples of body liquids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/20Surgical instruments, devices or methods, e.g. tourniquets for vaccinating or cleaning the skin previous to the vaccination
    • A61B17/205Vaccinating by means of needles or other puncturing devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023Drug applicators using microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0046Solid microneedles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0053Methods for producing microneedles

Abstract

A percutaneous agent delivery or sampling device (10, 88, 98, 104) comprising a sheet (6) having a plurality of microblades (4) for piercing and anchoring to the skin for increasing transdermal flux of an agent and for improving the attachment of the device (10, 88, 98, 104) to the skin. The device comprises a sheet (6) having at least one opening (8) therethrough and a plurality of blades (4) extending downward therefrom, and an anchoring means for anchoring the device (2) to the body surface.

Description

DELIVERY OR SAMPLING
' 3 lrield of the invention s The present invention relates to transdem~al agent delivery and sampling.
More particularly, this invention relates to the transdermal delivery of agents, such as a peptides and proteins, as well as the transdermal sampling of agents, such as glucose, s body electrolytes and substances of abuse, such as but not limited to alcohol and illicit 1o drugs. The present invention uses skin-piercing microblades to enhance the 1, transdermal flux of the agents during transdermal delivery or sampling and anchoring 12 elements to assist in retaining the delivery or sampling device in the skin.

14 Backctround of the invention 1s interes~ in the percutaneous or transdermal delivery of peptides and proteins to the human body continues to grow with the increasing number of medically useful 1a peptides and proteins becoming available in large quantities and pure foml.
The 1s transdermal delivery of peptides and proteins still faces significant problems. In many Zo instances. the rate of delivery or flux of poiypeptides through the skin is insufficient to produce a desired therapeutic effect due to the binding of the polypeptides to the skin.
In addition, pofypeptides and proteins are easily degraded during and after penetration 23 into the skin, prior to reaching target cells. Likewise, the passive flux of water soluble z4 small molecules such as salts is limited.
is One method of increasing the transdermal delivery of agents relies on the is application of an electric current across the body surface or on "eiectrotransport".
"Eiectrotransport" refers generally to the passage of a beneficial agent, e.g., a drug or 2s drug precursor. through a body surface such as skin, mucous membranes.
nails. and is the like. The transport of the agent is induced or enhanced by the application of an so electrical potential, which results in the application of electric current, which delivers or s, enhances delivery of the agent. The electrotransport of agents through a body surface ,..nm-", n,.,~,m., ~ ~._ ..__.. ~ , ~~ CA 02253549 1998-11-OS .._. ,.._~ ., _ . . . 1 . . J J -
2 1 may be attained in various manners. one widely used electrotransport a process, iontophoresis, involves the electrically induced transport of charged
3 ions. Electroosmesis, another type of eiectrotranspart process, involves the a movement of a solvent with the agent through a membrane under the influence of an electric field. Electroporation, still another type of electrotransport, n involves the passage of an agent through pores formed by applying a high voltage electrical pulse to a membrane. fn many instances, more than one of a these processes may be occurring simultaneously to different extents.
9 Electrotransport delivery generally increases agent delivery, particularly peptide zo delivery rates, relative to passive or non-electrically assisted transdermai delivery. However, further increases in transdermal delivery rates and iz reductions in peptide degradation during transdermal delivery are highly a 3 desirable.
:~ One method of increasing the agent transdermal delivery rate involves 15 pre-treating the skin with, or alternatively co-delivering with the beneficial agent, s a skin permeation enhancar. The term "per~neavon enhancer" is broadly used > ? herein to describe a substance which, when applied to a body surface through la which the agent is delivered, enhances its electrotransport flux. The s mechaliism may involve a reduction of the electrical resistance of the body 2o surface to the passage of the agent therethrough, an increase in the zi permeability of the body surface, the creation of hydrophilic pathways through zz the body surface, andlor a reduction in the degradation of the agent (eg, z 3 degradation by skin enzymes) during electrotransport.
z a There have been many mechanical attempts to enhance transdermal zs flux, such as, U. S. Patent Nos, 5,279,544 issued to Gross et al., 5,250,023 zs issued to Lee et al., and 3,984,482 issued to Gerstei et at and WO 98117&48 z~ published June 13, 1998, These devices utilize tubular or cylindrical structures ze generally, ahthough Gerstel and W4 98117848 do disclose the use of other z g shapes, to pierce the outer layer of the skin, Each of these devices-provide so manufacturing challenges, limited mechanical attachment of the structure to the a~ skin, andlor undesirable ir>~itatioh of the skin.

As has been discussed, a variety of chemicals and mechanical means have been explored to enhance transdermal flux. However, there is still a need to provide a device suitable for increasing transdermal flux which device is low-cost and which can be manufactured reproducibly (i.e., without significant variation from device to device) in high volume production and to improve the attachment of the device to the skin.
Description of the Invention The present invention provides a reproducible, high volume production, low-cost device suitable for increasing transdermal flux and improving attachment to the skin with minimal to no skin irritation. The device generally comprises a structure that attaches to the skin more effectively than the prior art devices. The invention comprises a plurality of microblades for piercing and anchoring to the skin. The blades typically have a length of less than about 0.4 mm and a width and thickness which is even smaller. In spite of their small size, the blades can be made with an extremely reproducible size and shape so that the microslits formed by the blades puncturing the skin also have a very reproducible size and depth. Because the blades have a small thickness (i.e., small relative to the width and length of the blades), the blades produce less tissue damage for a given cross-section 'than a skin piercing microneedle having a circular cross-section. The device of the present invention pierces the stratum corneum of a body surface to form pathways through which a substance (e.g., a drug) can be introduced (i.e., delivery) or through which a substance (e. g., a body electrolyte) can be withdrawn (i.e., sampling).

3a According to a broad aspect of the invention, there is provided a device for piercing the stratum corneum of a body surface to form pathways through which an agent can be introduced or withdrawn, comprising a sheet having at least one opening therethrough and a plurality of blades extending downward therefrom, the device characterized by:
at least one of the plurality of blades having an anchor for anchoring the device to the body surface, the sheet and the plurality of blades being substantially impermeable to the passage of the agent.
According to another broad aspect of the invention, there is provided a method for producing a device for piercing the stratum corneum of a body surface, the method comprising: applying a layer of a photo-resist selected from the group consisting of wet resist and dry resist to a first side of a sheet; exposing the layer of photo-resist through a mask pattern for :producing a plurality of blades; etching exposed portions of the photo-resist and the sheet to produce the plurality of blades and openings through the sheet; punching the plurality of blades through the openings such that the plurality of blades extend downward from the sheet; and incorporating the device for piercing the stratum corneum into a delivery device or a sampling device.
According to a further broad aspect of the invention, there is provided a method of transdermally sampling an agent, comprising: a. placing a device on a body surface through which the agent is to be withdrawn, the device including a sheet having at least one opening therethrough and a plurality of blades e:~tending downward therefrom whereby agent transmitting pathways are formed through the stratum corneum at the body :surface, and a reservoir in agent-transmitting relation with the opening;

3b b. withdrawing the agent through the pathways and said opening; and c. collecting the agent in the reservoir.
In one aspect of the invention, the device comprises a sheet having a plurality of openings therethrough, a plurality of microblades integral therewith and extending downward therefrom, and means for anchoring the device to a body surface. In the many different aspects of the invention, the device is anchored to the body surface in any of plurality of ways, including but not limited to, having an extension such as a prong or barb extending from at least some of the microblades, having an opening extending perpendicular through at least some of the microblades, covering essentially the entire surface area of the skin contacting surface of the device with adhesive except
4 PCT/US97/10516 for one side of the microblades, orienting at least some of the plurality of microblades at z an angle of 90° to the remainder of the plurality of microblades, orienting at least some s of the plurality of microblades at an angle within a range of about 1 ° to about 89° with a respect to the remainder of the plurality of microblades, providing a plurality of second s openings through the sheet which make the device more shapeable with respect to the s body surface. The device of the present invention can be used in connection with drug delivery, body analyte or drug sampling, or both. Delivery devices for use with the present invention include, but are not limited to, electrotransport devices, passive s devices, osmotic devices and pressure-driven devices. Sampling devices for use with the present invention include, but are not limited to, "reverse"
electrotransport devices as disclosed in Glikfeld et al., U.S. Patent No. 5,279,543, passive devices, osmotic ~z devices and negative pressure driven devices.
The present invention also provides a high yield, low-cost method for producing, in extremely reproducible fashion, the device of the present invention.
~s ~s Brief Description of the Drawin4s ~s Figure 1 is a perspective exploded view of one embodiment of an electrotransport agent delivery system with a blade array device according to one zo embodiment of the present invention;
z~ Figure 2 is an enlarged perspective view of the skin proximal side of the blade zz array device in accordance with one embodiment of the present invention;
z3 Figure 3 is a partial top plan view of a blade array pattern in accordance with za one embodiment of the present invention for forming blades with anchoring elements;
is Figure 4 is partial top plan view of yet another embodiment of the blade array 2s pattern of Figure 3;
Figure 5 is an enlarged view of a portion of the blades of the blade array pattern zs of Figure 3;
zs Figure 6 is an enlarged view of a blade tip in accordance with one embodiment so of the present invention;
5 PCT/LTS97/10516 Figure 7 is an enlarged view of a blade tip in accordance with another z embodiment of the present invention;
- 3 Figure 8 is a diagrammatic representation of a method for producing blades of a the present invention from the blade array pattern of figure 3;
s Figure 9 is an enlarged cross-sectional view of angled blades in accordance s with one embodiment of the present invention;
Figures 10, 11 and 12 are yet other embodiments of the blades with anchoring a elements of the present invention;
s Figure 13 is a right side elevational view of another embodiment of a blade with ,o an anchoring element;
Figure 14 is an end view of the blade of figure 13;
~z Figures 15 and 16 are another embodiment of the blade and an anchoring element;
~a Figure 17 is a right side elevational view of a blade with anchoring elements in accordance with one embodiment of the present invention;
Figure 18 is a cross-sectional view taken along line 18-18 of figure 17;
Figure 19 is a right side elevational view of another embodiment of a blade with an anchoring element;
~s Figure 20 is an enlarged partial top plan view of still another embodiment of the zo blade array pattern;
z~ Figure 21 is an enlarged partial top plan view of yet another embodiment of the zz blade array pattern;
zs Figure 22 is a bottom plan view of the electrotransport agent delivery system of za figure 1;
25 Figure 23 is a right side efevational view of the electrotransport agent delivery zs system of figure 7 ;
z~ Figure 24 is a rear elevational view of the efectrotransport agent delivery system zs of figure 1;
zs Figure 28 is a cross-sectional view taken along line 25-25 of the assembled so electrotranspc~rt agent delivery system of figure 23;
6 PCT/US97/10516 -Figure 26 is a diagrammatic cross-sectional view of a passive agent delivery z system in accordance with one embodiment of the present invention;
Figure 27 is a diagrammatic cross-sectional view of another embodiment of a a passive agent delivery system in accordance with the present invention;
s Figure 28 is a diagrammatic cross-sectional view of a sampling system in s accordance with one embodiment of the present invention; and Figure 29 is a diagrammatic cross-sectional view of another embodiment of the s blades of the present invention.
s ~o Modes for Carrying Out the Invention ~z Turning now to the drawings in detail, one embodiment of the device 2 of the ~s present invention is generally shown in Figure 1 for use with electrotransport delivery ,4 device 10. Device 2 is used for the percutaneous administration or sampling of an ,s agent. The terms "substance", "agent" and "drug" are used interchangeably herein and ,s broadly include physiologically or pharmacologically active substances for producing a localized or systemic effect or effects in mammals including humans and primates, ~a avians, valuable domestic household, sport or farm animals, or for administering to laboratory animals such as mice, rats, guinea pigs, and the like. These terms also zo include substances such as glucose, electrolyte, alcohol, illicit drugs, etc. that can be z~ sampled through the skin. The major barrier properties of the skin, such as resistance zz to drug penetration, reside with the stratum comeum. The inner division of the z3 epidermis generally comprises three layers commonly identified as stratum z4 granulosum, stratum malpighii, and stratum germinativum. Once a drug penetrates zs below the stratum corneum, there is substantially less resistance to permeation through zs the underlying stratum granulosum, stratum malpighii, and stratum germinativum layers z~ for absorption and circulation of drug into the body. The device of the present invention zs is used to form microslits in the stratum corneum and produce a percolation area in the zs skin for improved transdermal delivery or sampling of an agent.
7 PCT/US97/10516 Device 2 comprises a plurality of microbiades 4 (i.e., a blade array) extending z downward from one surface of a sheet or plate 6 (see Figure 2 in which device 2 is in s an inverted position to show the microblades). The microblades 4 penetrate the a stratum corneum of the epidermis when pressure is applied to the device to increase s the administration of or sampling of a substance through a body surface. The term s "body surface" as used herein refers generally to the skin, mucous membranes, and nails of an animal or human, and to the outer surface of a plant.
a Furthermore, the device 2 of the present invention improves the attachment of s the device to the skin so that the percolation areas and a continuous pathway are ~o preserved during movement of the body surface. fn the embodiment shown in Figure 2, projections in the form of barbs 50 on at least one of the blades 4 assist in anchoring ~z the device 2 and any corresponding device or structure used in combination therewith to the skin. Earbs 50 can be on any number of the blades from one blade to all blades.
Other embodiments which assist to anchor the device to the skin will be discussed ~s below.
,s The microblades 4 are generally formed from a single piece of material and are sufficiently sharp and long for puncturing the stratum corneum of the skin. In one ~a embodiment, the microblades 4 and the sheet 6 are essentially impermeable or are ~s impermeable to the passage of an agent. The sheet 6 is formed with an opening 8 zo between the microblades 4 for enhancing the movement of an agent therethrough. In z, the case of therapeutic agent (e.g., drug) delivery, the drug is released from a zz drug-containing reservoir (not shown in Figure 2) through microslits formed by the 23 microblades 4 cutting through the stratum corneum, migrating down the outer surfaces z4 of the microblades and through the stratum comeum to achieve local or systemic zs therapy. In the case of agent (e.g., body analyte) sampling, the analyte migrates from zs the body through the microslits in the stratum corneum which are cut by the z~ microblades 4. in one embodiment, the opening 8 corresponds to the portion of the za sheet 6 occupied by each of the microblades 4 prior to the blades being zs transpositioned into the downward depending position. The number of microblades 4 so per opening can be any number, preferably however between 1 and about 30 blades 3, per opening. Furthermore, the number of openings per device and the number of
8 PCT/US97/10516 blades per device are independent. The device may have only one opening and one 2 microblade. The agent can be administered at a controlled rate of release from the reservoir throe;gh an agent release rate controlling material (not shown) covering the a openings 8.
s As is best shown in Figure 2, the microblades 4 have a thickness which is much s smaller than the width of the blades near their base, i.e., near the point where the blades are attached to the plate 6. This blade geometry provides maximum drug s percolation area with a minimum blade penetration area, and hence less tissue s damage. The drug percolation area is the skin area in contact with the blades which provides for drug penetration in the skin. The microblades are shaped with the largest > > possible surtace area with a minimal cross-sectional area so as to give the largest possible percolation area. Thin microblades are better than round protrusions for this ~s purpose because for the same cross-section, a thin microblade produces more percolation area and less tissue damage than a round protrusion. This is a crucial ~s advantage over the prior art round elements such as needles and tubes. Thin ~s microblades a~so require less insertion force than round protrusions. The width of each blade can be any of a range of widths. The widths can be different from blade to blade ~a in the array pattern. Likewise, the width can be variable along the length of the blade, as will be described in more detail below. The width of the blade at the intersection of zo the blade and the body surface after the blade array has been inserted is preferably in the range of about 25 pm to about 500 pm, more preferably about 50 ~m to about z2 ~,m, more preferably 100 ~,m to about 300 pm.
z3 In one embodiment, the microblades 4 (Figure 5) are also provided with slanted 24 (i.e., angled) leading edges 64 to further reduce the insertion force required to press Zs the microblades into the skin tissue. The angle of the leading edge is designated as a.
Zs The slanted leading edges produce a cut through the skin tissue that is equal to the full z~ width of the blade 4 while reducing the amount of metal that is in the skin tissue. In zs other words, a fiat leading edge (i.e., a is 90°) produces a blade with a larger amount of is blade material in the skin tissue than is produced by a blade having a slanted leading 3o edge. The leading edges of each glade can all be the same angle or can be at s, different angles as shown in Figure 5. The angle a of each leading edge can be any
9 PCTIUS97/10516 -~ angle between about 10° to 90°, preferably between about
10° to 60°, more preferably z about 10° to 40°. The leading edge can also be segmented into two sections at s different angles. For example, the first segment can have an angle a between about a 10° to 40° and then transition to a second segment having an angle between 20° to s 60°. Alternatively, the leading edge of each blade can be arcuate (i.e., curved) in s shape, having, for example, a convex or concave shape. In one embodiment, the leading edge ~s a curved tip across the entire width of the blade.
a The microblades 4 are formed using a photo-etching process which is described s in detail hereinafter. This process allows the microblades 4 to be reproducibly formed on a very small (i.e., tens of microns) scale. This process also allows the microblades > > 4 to be formed in shapes which help anchor device 2 to the skin. In one embodiment, ~z the microblades 4 are provided with barbs 50 (Figures 2, 3 and 5) in some fashion so ~s that the device 2 and any corresponding device attached thereto stays attached to the ~4 skin after being applied with pressure. The degree of attachment and the number and ~s size of the barbs is such as to retain the delivery or sampling device during the normal ~s activity of the wearer; but not cause pain upon removal. As the microblades are pressed into the skin tissue for use, the leading edge 64 of each microblade cuts through and pushes aside the skin tissue. After the microblades have come to rest in ~s the skin, the skin due to its elastic nature at least partially comes back together around zo the edges of the microblades, in this way the surface 66 on each microblade having a z~ barb 50 engages skin tissue and anchors the device in the skin. If the blade is left in zz the skin for an extended period of time (e.g., 24 hours), the skin tissue begins to heal z3 together in the area behind the surface 66 of the barb thus improving the anchoring of za the device. Only one barb per blade is shown in the figures but it is within the scope of zs the present invention that each blade can have a plurality of barbs extending therefrom.
zs The microblades, in one embodiment, have a cross-section that is wider in the area of z~ the skin distal end of the blade than in the area of the skin proximal end, thus providing zs additional anchoring of the distal end in the skin. For example, the blades can have an zs "arrowhead" shape. Furthermore, the barbs 50 shown in the figures are in the same so plane as the blade, however the barbs can be oriented outside of that plane for s~ example by a separate bending step or by using a shaped punch and die to produce a WO 97/48440 1 ~ PCT/US97/10516 curve in the blade and barb. Curving the tips of the blade outside the plane of the 2 blade generally provides better anchoring. Insertion of such blades causes the barbs s to curve in the curve direction but retraction causes them to return to their prior position.
a The resulting curved cross-section of the blade can be, but is not limited to, angular, s semi-circular, C-shaped, or banana-shaped, to effect a larger cross-section of openings s in the skin.
z The plurality of blades 4 for puncturing the stratum corneum are present on one s face surface 48 of the device 2 in any predetermined arrangement, for example, as a s cluster of blades spaced in rows having any desired number, or in any spaced apart ~o relation of one blade to each other. The device 2 of the embodiment shown in Figures 1 and 2 is produced by the pattern shown in Figure 3. Each blade has a width and thickness that facilitates penetration of the stratum corneum without bending.
In the embodiment of Figure 3, there are six blades 4 in each opening 8 in sheet 6.
Each opening 8 in this embodiment is 1 mm long and 300 g,m wide. Correspondingly, the ~s width of each blade is between about 137.5 g.m to about 175 ~m and the length is about 250 ~.m. The required length of the blades is subject to variation of the body surface being penetrated and corresponds to the natural thickness of the stratum ~s corneum, for one of the principle features of the invention is that the blades are to ,s penetrate the stratum corneum into the epidermis. Usually, the blades will be about 25 ~m to about 400 ~m in length, with the length for most applications being between about 50 ~.m to about 200 Vim.
Zz The pattern for any of the blade array devices of the present invention are produced witl-~ a photo-etching process. A thin sheet or plate 6 of metal such as 24 stainless steel or titanium is etched photo-lithographically with patterns containing 2s blade-like structures. In general, a thin laminate dry resist or wet resist is applied on a is sheet about 7 ~.m to about 100 g.m thick, preferably about 25 ~.m to about 50 ~m thick.
The resist is contact exposed using a mask having the desired pattern and is 2e subsequently developed. These operations are conducted in much the same way that zs they are for the manufacture of a printed circuit board. The sheet is then etched using 3o acidic solutions. After the pattern has been etched through the sheet, the sheet is s, placed on a die 52 (shown schematically in figure 8) having a plurality of openings 56 WO 97/48440 ~ ~ PCT/US97/10516 corresponding to the openings 8 in-the sheet. A punch 54 having a plurality of z protrusions 5F3 corresponding to the openings in the sheet and die is initially located s above the sheet and die. At the initial stage, the blades 4 are in the same plane as the a rest of the sheet 6. The protrusions 58 on the punch 54 are then pressed into the s openings 56, thus bending the blades 4 downward to be at an angle (e.g., substantially s perpendicular) to the plane of the sheet. The finished structure provides blades 4 with an adjacent opening 8 for the passage of a substance therethrough when the device 2 a is applied to the skin. Rectangular openings 8 are shown in the figures but the s invention encompasses the use of any shape openings including, but not limited to, ,o square, triangular, circular and elliptical.
The sheet 6 in some areas can have additional etched openings 80 (Figure 4) to ,z alleviate the curl created during punching and/or to provide for flexibility in the dense ,3 blade array patterns because in some embodiments the sheet becomes very stiff after ,4 punching. The openings can be any of a variety of shapes (e.g., rectangular, circular, ,s elliptical, triangular, etc.) The openings also allow the sheet to be more easily curved to ,s match the curvature of the body surface to which it is to be attached which improves anchoring of the device. The present invention maximizes the openings through the ,s sheet but with a sufficient number of horizontal and vertical continuous portions in the ,s sheet to prevent the sheet from being too flexible (i.e., flimsy). If the openings are zo made too long in any one dimension, the sheet will bend (i.e., crinkle). In addition, it is z, also possible to treat the devices after punching with heat or plastic deformation such zz that the radius of curvature of the sheet becomes equal to or somewhat smaller than z3 the curvature of the body, where it is to be attached to enhance anchoring.
The z4 concave surtace can be shaped to match the convex pattern of the body.
zs The blades 4 can be patterned with resist on both sides 48,49 and subsequently is etched simultaneously from both sides (Figure 7) to achieve maximum pattern z~ resolution for a given sheet thickness and to produce a knife-like edge that can not be zs achieved with conventional stamping and punching processes. Alternatively, the zs blades 4 can be patterned and etched from one side (i.e., side 49) only (Figure 6).
so When etching from one side only,. the etching process can be controlled to etch s, selective depths in the plate 6 along the length of the blades (e.g., at the blade tips) to WO 97/48440 ~ 2 PCT/US97/10516 produce a single angle 60 at the tip of the blade which maximizes the sharpness of the z knife-like edge of the blade. In this embodiment, the lithography process produces a s portion of the blade that is thinner than the remainder of the thickness of the blade and a of the sheet. The lithography process also can produce very small dimensioned s elements for the anchoring and the penetration aspects of the invention.
s In another embodiment of the two-sided etching process, the blade array pattern of any of the embodiments of the present invention is etched into the top surface 49 of a sheet 6. A second pattern equivalent to the area bounded by each of the openings 8 s {e.g., rectangular) is etched into the bottom surface 48 such that each of the blades in ~o the blade array pattern is thinner than the surrounding sheet 6. As a result, the sheet 6 forms a strong base and as the punch 54 deforms the blades 4 downward, each of the ~z blades plastically deforms so as to produce blades that are straighter and more truly ~s perpendicular to the sheet.
~a In one embodiment of the etching process, a dry resist (e.g., "Dynachem FL"
~s available from Dynachem located in Tustin, CA) is applied 12.5 ~.m thick to one or both sides of the sheet and exposed in a standard manner. Then a suitable spray etcher (e.g., "Dynamil VRP 1 O/NM" available from Western Tech. Assoc. located in Anaheim, ~s CA) is used to spray a mixture of ferric chloride and hydrochloric acid onto the resist and sheet at 52 °C (125 °F) for two minutes. A standard caustic stripper is used for the zo resist removal.
z~ In another embodiment of the etching process, a wet resist (e.g., "Shipley 111 S"
zz available from Shipley Corporation, located in Marlborough, MA) is applied 7.5 ~.m thick zs at about 20 °C (70 °F) to one or both sides of the sheet and exposed in a standard 24 manner. Then a suitable etchant (e.g., ferric chloride) is sprayed onto the resist and zs sheet at 49 °C (120 °F). A standard caustic stripper is used for the resist removal.
2s Generally, the blades 4 are at an angle of about 90° to the surface 48 of the z~ sheet 6 after being punched, but they can be disposed at any angle forward or za backward from the perpendicular position that will facilitate penetration of and zs attachment to the stratum comeum. In one embodiment (Figure 9), the blades are all so aligned at an angle between about 1 ° and about 89° degrees, preferably about 10° to about 60°, more preferably about 20° to 45° to facilitate the device being slid along and WO 97/48440 ~ 3 PCT/US97/10516 into the skin. The angled blades have two principal advantages. First, penetration of z the blades is not opposed by the elasticity of the skin because the blades are slid horizontally into the skin as opposed to pressing vertically on the skin.
Second, the a angled blades act to anchor the device in the skin as any motion of the skin is less s likely to dislodge the blades. In addition, other anchoring elements such as barbs, s openings, etc. can be used with the angled blades to further enhance anchoring of the device.
s In one embodiment (Figure 29), anchoring of the device is achieved by coating s the surtace 48 of sheet 6 and surface 82 of each blade 4 with an adhesive.
One method of producing this embodiment comprises spraying the adhesive on the device 2 along the direction indicated by arrows 84. In this embodiment, the agent is free to ~z pass through the openings 8 and along surtace 86 of each blade unencumbered by the adhesive. It is also possible to apply the adhesive on only surface 48 and not on the ~a blade surfaces 82. This can be accomplished, for example, by applying the adhesive ~s onto surface 48 after the blades 82 have been punched by spraying the adhesive in a direction which is parallel to the axis of the blades 82. It is further possible to apply the adhesive only on the blade surtaces 82 and not on the surface 48 of sheet 6 in order to ~a anchor the device, although this last design is the least preferred adhesive anchoring means.
zo The sheet and blades can be made from materials that have sufficient strength z~ and manufacturability to produce blades, such as, glasses, ceramics, rigid polymers, z2 metals and metal alloys. Examples of metals and metal alloys include but are not zs limited to stainless steel, iron, steel, tin, zinc, copper, platinum, aluminum, germanium, z4 nickel, zirconium, titanium and titanium alloys consisting of nickel, molybdenum and zs chromium, metals plated with nickel, gold, rhodium, iridium, titanium, platinum, and the zs like. An example of glasses include a devitrified glass such as "Photoceram" available z7 from Corning in Coming, NY. Examples of rigid polymers include but are not limited to 28 polystyrene, potymethyimethacrylate, polypropylene, polyethylene, "Bakelite", cellulose zs acetate, ethylcellulose, styrenelacrylonitrile copolymers, stryrenetbutadiene so copolymers, acrytonitrile/butadiene/styrene (ABS) copolymers, polyvinyl chloride and s, acrylic acid polymers including polyacrylates and polymethacrytates.

Very dense patterns can be created with unit cells wherein a unit cell has a z width A and a length B as illustrated in Figure 3. In one embodiment (not shown), the 3 pattern has the following characteristics: a unit cell area of 0.63 mm by 3.8 mm; the a lineal length of a cut in a unit cell is approximately equal to 15 mm; and the open skin s length per square centimeter is 625 mm.
s The microbiades of the present invention make an elongated, thin microcut (i.e., a slit) in the skin surtace because the blades have a small thickness (relative to their a width and length) resulting in a minimal blade cross-sectional area for the portions of s the blade in the skin. The geometry of the microblades 4 results in minimal blade volume in the skin with maximal blade surtace area in the skin. The advantages of the o present invention include, but are not limited to: (1) the thin blade geometry produces ~z the maximum drug percolation area for a given cross-section of the blade;
(2) minimal tissue damage occurs because the amount of blade material in the skin and hence the volume loading is minimized; (3) slanted leading edges (or equivalent pointed shapes) ~s further minimize the amount of volume loading or tissue damage while preserving a large percolation area; (4) for a given volume loading, the larger the surface area, the larger the frictional retaining force in the skin; and (5) for a given desired percolation area, there are fewer blades necessary and therefore the force on each tip is higher ~s . making skin penetration easier.
zo In other embodiments (Figures 10-16) other anchoring elements are used in the z~ present invention. In the embodiments shown in Figures 10-14, prong 68 is etched in zz the side of some or all of the blades 4, and punched lightly so as to protrude outward zs from the plane of each of the blades, as illustrated in Figures 10 and 14.
After the za punching of the prongs, the blades may be repunched to regain their substantially zs vertical orientation. Hinges 72 (Figure 13) can be used to control the retention force of zs the barb for anchoring. The hinges allow for the retention force to be tailored z7 independently of the size of the blade because the force required to bend or punch the zs prong is set independently of the size of the blades by the shape or size of the hinge. In zs other words, the force can be tailored by the amount of attachment of the prong to the so plate, the greater the attachment, the greater the force.

WO 97/48440 15 PCT/US97/10516 w Prongs may protrude from either side of the blade, or both sides, if desired.
The z shape of each prong can be any of a variety of shapes such as triangular, square, etc.
s as shown in Figures 11 and 12. In another embodiment, a curved protrusion 70 a (Figures 15 and 16) is made by etching a slit in some or all of the blades followed by s punching. The prongs and curved protrusions act to anchor the device in the skin s similar to the manner described previously.
In other embodiments other anchoring elements are used. In the embodiments a of Figures 17-19, the blade 4 has additional openings 74 extending through the blade s to enhance anchoring. The edges forming the holes or other linear openings are ,o etched through the blade. Alternatively, or in addition, numerous small pits (i.e., indentations) rather than holes can be etched in the surface of the blade. As described ,z above, the elastic nature of the skin tissue causes the skin to move into the openings or pits. In the embodiments with openings, the skin tissue may heal and reconnect through the openings to provide even greater anchoring.
~s In a further embodiment (Figure 20), a plurality of blades in an opening 8 are ~s arranged at 90° to another plurality of blades in an opening 8' such that anchoring in » two directions is obtained. in other words, the blades (not shown) associated with the ~s openings 8 are oriented parallel to the edge 76 of the device 2 and the blades (not ,s shown) associated with the openings 8' are oriented parallel to the edge 78 of the zo device. The blades associated with each opening 8 can be oriented at any angle with z~ respect to the blades associated with each opening 8'. Alternatively, the blades within zz each opening can be along perpendicular sides of the openings. In a similar manner, zs the blades within each opening can be formed in a serrated pattern as illustrated in za Figure 21. This pattern allows the blades to have different, controllable angles with zs respect to each other defined by the angle of the punch used and the etched angle (3 of zs the pattern.
27 The number of blades and openings of any of the embodiments of the device 2 za is variable with respect to the desired flux rate, agent being sampled or delivered, zs delivery or sampling device used (i.e., electrotransport, passive, osmotic, so pressure-driven, etc.), and other factors as will be evident to one of ordinary skill in the art. In general, the larger the number of blades per unit area (i.e., the blade density), the more distributed is the flux of the agent through the skin because there are a z greater number of agent-conveying pathways through the skin. Consequently, the s smaller the number of blades per unit area, the more concentrated is the flux of the a agent through the skin because there are fewer pathways. The present invention has a s blade density of at least about 10 bladeslcmz and less than about 1000 bladeslcm2, s preferably at least about 600 bladeslcm2, more preferably at least about 800 blades/cm2. In similar fashion, the number of openings per unit area through which the a agent passes is at least about 10 openings/cm2 and less than about 1000 s openingslcm'. In one embodiment, the present invention produces a percolation area of about 0.005 to .05 cmZlcmz of body surface, preferably about 0.01 cm2/cmz of body surtace.
One embodiment of the present invention relies on the application of an electric ~s current across the body surtace or "electrotransport". Electrotransport refers generally to the passage of a beneficial agent, e.g., a drug or drug precursor, through a body ~s surtace such as skin, mucous membranes, nails, and the like. The transport of the agent is induced or enhanced by the application of an electrical potential, which results in the application of electric current, which delivers or enhances delivery of the agent ~s or, for "reverse" electrotransport, samples or enhances sampling of the agent. The electrotransport of the agents into the human body may be attained in various manners.
zo One widely used electrotransport process, iontophoresis, involves the electrically induced transport of charged ions. Electroosmosis, another type of electrotransport ~z process involved in the transdermal transport of uncharged or neutrally charged Zs molecules (e.g. transdermal sampling of glucose), involves the movement of a solvent 24 with the agent through a membrane under the influence of an electric field.
zs Electroporation, still another type of electrotransport, involves the passage of an agent is through pores formed by applying an electrical pulse, a high voltage pulse, to a membrane. In many instances, more than one of these processes may be occurring 2a simultaneously to different extents. Accordingly, the term "electrotransport" is given 2s herein its broadest possible interpretation, to include the electrically induced or so enhanced transport of at least one charged or uncharged agent, or mixtures thereof, regardless of the specific mechanisms) by which the agent is actually being z transported.
s It will be appreciated by those working in the field that the present invention can a be used in conjunction with a wide variety of electrotransport drug delivery systems, as - s the invention is not limited in any way in this regard. For examples of electrotransport s drug delivery systems, reference may be had to U.S. Patent Nos. 5,147,29fi to Theeuwes et al., 5,080,646 to Theeuwes et al., 5,169,382 to Theeuwes et al., and a 5,169,383 to Gyory et al.
s Electrotransport devices generally use at least two electrodes which are in electrical contact with some portion of the skin, nails, mucous membranes, or other body surface. In the case of transdermal agent delivery, one of the two electrodes is commonly referred to as the "donor" or "active" electrode, and is the one from which the agent is delivered into the body. In the case of transdermal agent sampling, one of the ,a two electrodes is referred to as the "receptor" electrode, and is the one into which the ~s agent (e.g., body electrolyte) is collected upon being withdrawn from the body. The ,s second electrode is, typically termed the "counter" or "return" electrode, and serves to » close the electrical circuit through the body. For example, when the agent to be delivered is a cation, i.e., a positively charged ion, the anode becomes the active or donor electrode, while the cathode serves to complete the circuit.
Alternatively, if the Zo agent to be delivered is an anion, i.e., a negatively charged ion, the cathode is the donor electrode. When the agent to be sampled is a cation, the cathode becomes the zz receptor electrode while the anode serves to complete the circuit. When the agent to 23 be sampled is an anion, the anode becomes the receptor electrode white the cathode 24 serves to complete the circuit. When the agent to be sampled has no net charge (e.g., is glucose), then either the anode, or the cathode, or both electrodes, can serve as the is receptor electrode. Both the anode and cathode may be donor electrodes if both anionic and cationic agents are delivered simultaneously. Electrotransport delivery zs systems generally require at least one reservoir or source of the agent to be delivered 2s to the body. Electrotransport sampling systems likewise require at least one reservoir so in which to collect the agent being sampled. Examples of such reservoirs include a 3, pouch or cavity as described in U.S. Patent No. 4,250,878 to Jacobsen et al., a porous WO 97/48440 1 g PCT/US97/10516 sponge or pad as described in U.S. Patent No. 4,141,359 to Jacobsen et al., and a z pre-formed gel body as described in U.S. Patent No. 4,383,529 to Webster, among s others. Such reservoirs are electrically connected to, and positioned between, the a anode or the cathode and the body surtace, e.g., to provide a fixed or renewable s source of one or more drugs in the case of agent delivery. In addition, electrotransport s systems also typically have an electrical power source, e.g., one or more batteries, and an electrical controller designed to regulate the timing, amplitude and/or frequency of a the applied electric current, and hence regulate the timing and rate of agent s delivery/sampling. This power source component is electrically connected to the two electrodes. Optional electrotransport device components include a counter reservoir, adhesive coatings, insulating separation layers, and rate-controlling membranes.
~z Figures 1 and 22-25 illustrate a representative electrotransport ~s delivery/sampiing device 10 that may be used in conjunction with the present invention.
~a Device 10 comprises an upper housing 16, a circuit board assembly 18, a lower ~s housing 20, anode electrode 22, cathode electrode 24, anode reservoir 26, cathode ~s reservoir 28 and skin-compatible adhesive 30. Upper housing 16 has lateral wings 15 which assist in holding device 10 on a patient's skin. Printed circuit board assembly 18 comprises an integrated circuit 19 coupled to discrete components 40 arid battery 32.
Circuit board assembly 18 is attached to housing 16 by posts (not shown in Figure 1 ) zo passing through openings 13a and 13b, the ends of the posts being heated/melted in z~ order to heat stake the circuit board assembly 18 to the housing 16. Lower housing 20 zz is attached to the upper housing 16 by means of adhesive layer 30, the upper surface za 34 of adhesive layer 30 being adhered to both lower housing 20 and upper housing 16 z4 including the bottom surfaces of wings 15. Shown (partially) on the underside of circuit is board assembly 18 is a button cell battery 32. Other types of batteries may also be zs employed to power device 10 depending on the need.
z~ The device 10 is generally comprised of battery 32, electronic circuitry 19,40, za electrodes 22,24, druglreceptor reservoir 26, counter reservoir 28, and device 2, all of zs which are integrated into a self-contained unit. The outputs (not shown in Figure 1 ) of so the circuit board assembly 18 make _electrical contact with the electrodes 24 and 22 s~ through openings 23,23' in the depressions 25,25' formed in lower housing 20, by WO 97/48440 1 g PCT/US97/10516 means of electrically conductive adhesive strips 42,42'. Electrodes 22 and 24, in tum, z are in direct mechanical and electrical contact with the top sides 44',44 of drug reservoirs 2fi and 28. The bottom side 46 of drug reservoir 28 contacts the patient's a skin through the opening 29 in adhesive layer 30. The bottom side 46' of drug reservoir s 26 contacts the patient's skin through the plurality of openings 8 in the device 2. The s formulation of reservoir 26 is preferably a viscous gel that fills the openings 8 such that the reservoir 26 is in direct contact with the skin when the blades have penetrated the a stratum corneum. The contact between the reservoir and skin provides a path for the s agent to be transported along. If the reservoir 26 is not in direct contact with the skin initially typically sweat accumulates in the confined area and provides an agent-transmitting pathway between reservoir 26 and the skin.
~z Device 10 optionally has a feature which allows the patient to self-administer ,s a dose of drug, or self-sample a body electrorolyte, by electrotransport.
Upon ~4 depression of push button switch 12, the electronic circuitry on circuit board assembly 15 18 delivers a predetermined DC current to the electrodelreservoirs 22,26 and 24,28 for an interval of predetermined length. The push button switch 12 is conveniently located on the top side of device 10 and is easily actuated through clothing. A double press of ~s the push button switch 12 within a short time period, e.g., three seconds, is preferably used to activate the device, thereby minimizing the likelihood of inadvertent actuation of zo the device 10. Preferably, the device transmits to the user a visual andlor audible z~ confirmation of the onset of operation by means of LED 14 becoming lit andlor an zz audible sound signal from, e.g., a "beeper". Agent is deliveredlsampled through the z3 patient's skin, e.g., on the arm, by electrotransport over the predetermined interval.
za Anodic electrode 22 is preferably comprised of silver and cathodic electrode 24 is zs preferably comprised of silver chloride. Both reservoirs 26 and 28 are preferably zs comprised of polymeric gel materials. Electrodes 22,24 and reservoirs 26,28 are z~ retained by lower housing 20.
zs In the case of therapeutic agent (i.e., drug) delivery, a liquid drug solution or zs suspension is contained in at least one of the reservoirs 26 and 28. Drug so concentrations in the range of approximately 1 x 10'~ M to 1.0 M or more can be used, s~ with drug concentrations in the lower portion of the range being preferred.

WO 97/48440 2~ PCT/US97/10516 -The push button switch 12, the electronic circuitry on circuit board assembly z and the battery 32 are adhesively "sealed" between upper housing 16 and lower s housing 20. Upper housing 16 is preferably composed of rubber or other elastomeric a material, e.g., injection moldable ethylene vinyl acetate. Lower housing 20 is preferably s composed of a plastic or elastomeric sheet material (e.g., polyethylene) which can be s easily molded to form depressions 25,25' and cut to form openings 23,23'.
The z assembled device 10 is preferably water resistant (i.e., splash proof) and is most a preferably waterproof. The system has a low profile that easily conforms to the body, s thereby allowing freedom of movement at, and around, the wearing site. The reservoirs ,0 26 and 28 are located on the skin-contacting side of the device 10 and are sufficiently > > separated to prevent accidental electrical shorting during normal handling and use.
~z The device 10 adheres to the patient's body surface (e.g., skin) by means of an ~s adhesive layer 30 (which has upper adhesive side 34 and body contacting adhesive side 36) and the anchoring elements on the device 2 of any of the embodiments ~s discussed above. The adhesive side 36 covers the entire underneath side of the device 10 except where the device 2 and reservoir 28 are located. The adhesive side 36 has adhesive properties which assures that the device 10 remains in place on the ,e body during normal user activity, and yet permits reasonable removal after the ,s predetermined (e.g., 24-hour) wear period. Upper adhesive side 34 adheres to lower zo housing 20 and retains the electrodes and reservoirs wi#hin housing depression 25,25' z~ as well as retains device 2 to lower housing 20 and lower housing 20 to upper housing zz 16.
23 In one embodiment of the drug delivery or sampling device there is a bandage za cover (not shown) on the device 10 for maintaining the integrity of the device when it is zs not in use. In use, the bandage cover is stripped from the device before the device is zs applied to the skin.
z~ In other embodiments of the present invention, passive transdermal delivery or za sampling devices are used with device 2. Two examples of passive transdermal zs delivery or sampling devices are illustrated in Figures 26 and 27. In Figure 26, passive so transdermal delivery device 88 comprises a reservoir 90 containing agent.
Reservoir s~ 90 is preferably in the form of a matrix containing the agent dispersed therein.

WO 97!48440 21 PCT/US97/10516 Reservoir 90 is sandwiched between a backing layer 92, which is preferably 2 impermeable to the agent, and a rate-controlling membrane 94. In Figure 26, the s reservoir 90 is formed of a material, such as a rubbery polymer, that is sufficiently a viscous to maintain its shape. If a lower viscosity material is used for reservoir 90, such s as an aqueous gel, backing layer 92 and rate-controlling membrane 94 would be s sealed together about their periphery to prevent leakage. In a sampling configuration, the reservoir 90 would initially not contain the agent. Located below membrane 94 is a microblade array device 2. The device 88 adheres to a body surtace by means of s contact adhesive layer 96 around the periphery of the device 2 and by the anchoring ~o elements of any of the embodiments described previously. The adhesive layer 96 may optionally contain agent. A strippable release liner (not shown) is normally provided along the exposed surface of adhesive layer 96 and is removed prior to application of 13 device 10 to the body surface.
Alternatively, as shown in Figure 27, transdermal therapeutic device 98 may be ~s attached to a body surface by means of a flexible adhesive overlay 100 and the anchoring elements used in device 2. Device 98 is comprised of an agent-containing reservoir 90 (for a delivery configuration) which is preferably in the form of a matrix ,a containing the agent dispersed therein. In a sampling configuration, the reservoir 90 would initially not contain the agent. An impermeable backing layer 102 is provided 2o adjacent one surface of reservoir 90. Adhesive overlay 100 maintains the device 98 on the body surface in combination with the anchoring elements of any of the zz embodiments previously described for device 2. Adhesive overlay 100 can be 23 fabricated together with, or provided separately from, the remaining elements of the 24 device 98. Wiih certain formulations, the adhesive overlay 100 may be preferable to is the contact adhesive 96 shown in Figure 26. This is true, for example, where the agent is reservoir contains a material (such as, for example, an oily surfactant permeation enhancer) which adversely affects the adhesive properties of the contact adhesive is layer 96. Impermeable backing layer 102 is preferably slightly larger than reservoir 90, is and in this manner prevents the agents in reservoir 90 from adversely interacting with so the adhesive in overlay 100. Optionally, a rate~ontrolling membrane (not shown in s, Figure 27) similar to membrane 94 in device 88 (Figure 26) can be provided on the skin/mucosa side of reservoir 90. A strippable release liner (not shown) ~is also z normally provided with device 98 and is removed just prior to application of device 98 to s the body surface.
a The formulation for the passive transdermal devices may be aqueous or non-s aqueous based. The formulation is designed to deliver the drug at the necessary s fluxes. Aqueous formulations typically comprise water and about 1 to 2 weight percent of a hydrophilic polymer as a gelling agent, such as hydroxyethylcellulose or a hydroxypropylcellulose. Typical non-aqueous gels are comprised of silicone fluid or s mineral oil. Mineral oil-based gels also typically contain 1 to 2 weight percent of a ,o gelling agent such as colloidal silicon dioxide.
> > The reservoir matrix should be compatible with the delivered agent, any ,z excipients (e.g., flux enhancers, irritation preventing agents) and/or any carrier zs therefore. When using an aqueous-based system, the reservoir matrix is preferably a ~a hydrophilic polymer, e.g., a hydrogel. When using a non-aqueous-based system, the ~s reservoir matrir, is preferably composed of a hydrophobic polymer. Suitable polymeric matrices are well known in the transdermal drug delivery art.
m When a constant drug delivery rate is desired, the drug is present in the matrix ,a or carrier at a concentration in excess of saturation, the amount of excess being a zs function of the desired length of the drug delivery period of the system.
The drug may, 2o however, be present at a level below saturation without departing from this invention.
z~ In addition to the drug, the matrix or carrier may also contain dyes, pigments, zz inert fillers, permeation enhancers, excipients and other conventional components of zs pharmaceutical products or transdermal devices known in the art.
z4 The amount of drug present in the reservoir and the size of the reservoir is zs generally non-limited and is an amount equal to or larger than the amount of drug that, zs in its released form, is effective in bringing about the drugs physiological or z~ pharmacological local or systemic effects.
za The preferred form in which an agent is delivered or sampled generally zs determines the type of delivery or sampling system to be used, and vice versa. That is, so the selection of a "passive" system which delivers or samples the agent by diffusion or as an electrically powered system which delivers or samples the agent by electrotransport will be mostly determined by the form of the agent. For example, with passive delivery z systems, it has generally been recognized that the agent is preferably delivered in s either its free base or acid form, rather than in the form of a water soluble salt. On the a other hand, with electrotransport delivery devices, it has been recognized that the s drugs should preferably be ionized and the drug salt should be soluble in water. It is s generally believed that the pathways for passive and eiectrotransported transdermal drug delivery through intact skin are different, with passive delivery occurring through a lipid regions (i.e., hydrophobic regions) of the skin and electrotransport delivery s occurring through hydrophilic pathways or pores such as those associated with hair ,o follicles and sweat glands. For the case of pierced skin, there is substantial passive " flux through the microslits created by the microblades piercing the stratum corneum.
,z The drug for passive delivery is generally hydrophobic, e.g., free base form, whereas ,3 the preferred form of a drug for electrotransport delivery is hydrophilic, e.g., water ,4 soluble salt form. For osmotic and pressure driven systems which deliver or sample ,s drugs by connective flow carried by a solvent, the drug preferably has sufficient ,s solubility in the carrier solvent. It wilt be appreciated by those working in the field that » the present invention can be used in conjunction with a wide variety of osmotic delivery ,a or sampling systems, as the invention is not limited to a particular device in this regard.
,s Osmotic devices, available for use with the present invention, are disclosed for zo example in U.S. Patent Nos. 4,340,480 to Eckenhoff, 4,655,766 to Theeuwes et al., z, and 4,753,651 to Eckenhoff.
zz This invention has utility in connection with the delivery of drugs within any of 23 the broad class of drugs normally delivered through body surtaces and membranes, za including skin. In general, this includes drugs in all of the major therapeutic areas zs including, but not limited to, anti-infectives such as antibiotics and antiviral agents, zs analgesics including fentanyl, sufentanil, buprenorphine and analgesic combinations, z~ anesthetics, anorexics, antiarthritics, antiasthmatic agents such as terbutaline, zs anticonvulsants, antidepressants, antidiabetic agents, antidiarrheals, antihistamines, zs anti-inflammatory agents, antimigraine preparations, antimotion sickness preparations so such as scopolamine and ondansetron, antinauseants, antineopiastics, s, antiparkinsonism drugs, antipruritics, antipsychotics, antipyretics, antispasmodics, including gastrointestinal and urinary anticholinergics, sympathomimetrics, xanthine 2 derivatives, cardiovascular preparations including calcium channel blockers such as s nifedipine, betablockers, beta-agonists such as dobutamine and ritodrine, a antiarrythmics, antihypertensives such as atenolol, ACE inhibitors such as ranitidine, s , diuretics, vasodilators, including general, coronary, peripheral and cerebral, central s nervous system stimulants, cough and cold preparations, decongestants, diagnostics, hormones such as parathyroid hormone, bisphosphoriates, hypnotics, immunosuppressives, muscle relaxants, parasympatholytics, parasympathomimetrics, s prostaglandins, psychostimulants, sedatives and tranquilizers. The invention is also useful in conjunction with reducing or preventing sensitization occurring as a result of electrotransport delivery of proteins, peptides and fragments thereof, whether naturally occurring, chemically synthesized or recombinantly produced. The invention may additionally be used in conjunction with the delivery of nucleotidic drugs, including oligonucleotide drugs, polynucleotide drugs, and genes.
~s The present invention has particular utility in the delivery of peptides, ~s polypeptides, proteins, nucieotidic drugs, and other such species through body surfaces such as skin. These substances typically have a molecular weight of at least s about 300 daltons, and more typically have a molecular weight of at least about 300 to 40,000 daltons. Specific examples of peptides and proteins in this size range include, 2o without limitation, LHRH, LHRH analogs such as goserelin, busereiin, gonadorelin, napharelin and leuprolide, GHRH, GHRF, insulin, insultropin, calcitonin, octreotide, 22 endorphin, TRH, NT-36 (chemical name:
is N-[[(s)-4-oxo ,?-azetidinyl]carbonyl)-L-histidyl-L-prolinamide), liprecin, pituitary 24 hormones (e.g., HGH, HMG, desmopressin acetate, etc.), follicle luteoids, aANF, 25 growth factors such as growth factor releasing factor (GFRF), [iMSH, GH, somatostatin, zs bradykinin, somatotropin, platelet-derived growth factor, asparaginase, bleomycin sulfate, chymopapain, cholecystokinin, chorionic gonadotropin, corticotropin (ACTH), 2a erythropoietin, epoprostenol (platelet aggregation inhibitor), glucagon, HCG, hirulog, zs hyaluronidase, interteron, interfeukins, menotropins (urofollitropin (FSH) and LH), so oxytocin, streptokinase, tissue plasminogen activator, urokinase, vasopressin, desmopressin, ACTH analogs, ANP, ANP clearance inhibitors, angiotensin II

antagonists, antidiuretic hormone agonists, bradykinin antagonists, ceredase, CSI's, 2 calcitonin gene related peptide (CGRP), enkephalins, FAB fragments, IgE
peptide s suppressors, IGF-1, neurotrophic factors, colony stimulating factors, parathyroid a hormone and agonists, parathyroid hormone antagonists, prostaglandin antagonists, s pentigetide, protein C, protein S, renin inhibitors, thymosin alpha-1, thrombolytics, TNF, s vaccines, vasopressin antagonists analogs, alpha-1 antitrypsin (recombinant), and TGF-beta.
s As mentioned above, the device 2 of the present invention can also be used s with known sampling devices including, but not limited to, reverse iontophoresis, osmosis, passive diffusion, phonophoresis, and suction (i.e., negative pressure).
Figure 28 illustrates an osmotic sampling device 104 in combination with any of the embodiments described previously for device 2. Osmotic sampling devices can be ~s used to sample any of a variety of agents (e.g., body analytes, licit and illicit drugs) ~a through a body surtace including, but not limited to glucose, body electrolytes, alcohol, ~s blood gases, and illicit substances such as drugs of abuse. The osmotic sampling device 104 is attached to a body surface by means of a flexible adhesive overlay 100 and the anchoring elements of device 2. Device 104 is comprised of a salt layer 106 located between a semi-permeable or osmotic membrane 94 and an optional agent ,s sensing element 108. The optional agent sensing element can be any of a variety of 2o chemically reactive sensors and indicators, for example the color indicating test strips associated with glucose testing. The adhesive overlay 100 can have a cut-out or z2 transparent window in the area of the indicators so that the indicators can be readily is viewed. In an alternate embodiment, the agent sensing element can be located i4 between the device 2 and the salt layer.
is The following example is merely illustrative of the present invention and should is not be considered as limiting the scope of the invention in any way, as this example 27 and other equivalents thereof will become apparent to those versed in the art and in is light of the present disclosure, drawings, and the accompanying claims.

' ~ Example z s The effect of the present design was evaluated on the skin resistance of a a hairless guinea pig. A blade array of two square centimeters was applied to ECG
s electrodes of five square centimeters. The blade array and electrodes were then s applied to the skin of the animal. Resistance measurements were taken two minutes after application of the electrode to the skin of the animal. A decrease in resistance s was observed indicating that penetration of the blades into the skin had occurred.
s The device was evaluated for its effect on electrotransport flux of a decapeptide in the hairless guinea pig. The following are specifications for the device:
the device consisted of a sheet having a plurality of rectangular openings having six blades, three ,z on each long side of a 860 ~m by 250 ~.m rectangle resulting in a 0.22 mm2 open area for each opening. Each set of three blades started at the opposite end of the rectangle ~a as the opposing set of blades. All of the blades were about 200 ~m long.
All six blades ~s had slanted leading edges and the blade at each end was barbed as well. The group of six blades were arranged in two slightly offset rows with ten groups in each row on the sheet. Each device was a two cmZ piece of stainless steel 25 ~.m thick etched and ~s punched with eight pairs of offset rows or 160 groups of six blades for a total of 960 blades. There were 40 void areas per cmz and 240 blades per cm2.
zo For the study, a one compartment electrotransport system was used. It z, consisted of a cathode compartment containing a Dulbelco's phosphate buffered saline z2 imbibing gel and a donor anode compartment containing two millimoles of decapeptide zs buffered at pH 7.5, 7 0% cholestyramine chloride and 3%
hydroxyethylcellulose. After z4 loading the gels in the system, the release liner was removed from the adhesive foam zs bottom of the electrotransport system. The device was carefully applied over a 1.6 cm zs diameter hole containing the donor gel with the microblades facing away from the gel.
z~ The electrotransport system was then placed on the skin of a lightly anesthetized zs hairless guinea pig. The systems were applied to the backs of the animals using gentle Zs downward pressure while at the same time pushing bottom side of the system with the so thumb of the technician. (The thumtr trapped a roll of the animals' skin which allowed s, some upward pressure to be applied directly to the bottom side of the skin in contact with the device microblades). Affer two minutes the current and resistance 2 measurements were observed and recorded. The electrotransport system was s wrapped with Vetrap and the animals were returned to their cages for the duration of a electrotransport (5 and 24 hours). Decapeptide flux was evaluated by measuring s urinary excretion of this peptide. Only a modest effect of the device on decapeptide s flux was observed in the first five hours of transport. Between five and twenty four hours, the electrotransport flux of an ordinary electrotransport device dropped very s significantly probably due to collapse of the pathways or possibly aggregation of the s peptide in the pathways (the decrease in flux between five and twenty four hours was reproducible). Use of the blade array device completely prevented this decrease in flux and resulted in an overall ten-fold increase in decapeptide flux over a twenty four hour transport period.
While the invention has been described in conjunction with the preferred specific embodiments thereof, it is to be understood that the foregoing description as ,s well as the example are intended to illustrate and not limit the scope of the invention.
Other aspects, advantages and modifications within the scope of the invention will be apparent to those skilled in the art to which the invention pertains.

Claims (29)

WHAT IS CLAIMED IS:
1. A device (2) for piercing the stratum corneum of a body surface to form pathways through which an agent can be introduced or withdrawn, comprising a sheet (8) having at least one opening (8) therethrough and a plurality of blades (4) extending downward therefrom, the device (2) characterized by:
at least one of the plurality of blades having an anchor (50, 68, 74, 82) for anchoring the device (2) to the body surface, the sheet (6) and the plurality of blades (4) being substantially impermeable to the passage of the agent.
2. The device of claim 1, wherein the sheet (6) has a plurality of openings (8) therethrough, at least one of said openings (8) having a plurality of blades (4) located along a periphery thereof.
3. The device of Claim 9, wherein the anchor is selected from the group consisting of:
(i) a projection (68) extending out from the at least one blade (4);
(ii) a barb (50);
(iii) at least one opening (74) extending through at least one blade (4);
(iv) an adhesive on a body contacting surface (48) of the sheet (6) and on at least one surface (82) of at least one of the plurality of blades (4);
(v) each of the blades (4) having an axis, the blades (4) being oriented so that the blade axes are substantially parallel and the axes form an angle of about 1° to 89° relative to the sheet (8);
(vi) each one of the plurality of blades (4) defines essentially a plane and wherein the anchor comprises a portion of the plurality of blades (4) being oriented at an angle of about 90° with respect to a remaining portion of the plurality of blades; and (vii) each one of the plurality of blades (4) defines essentially a plane and wherein the anchor comprises a portion of the plurality of blades (4) being oriented at an angle within a range of about 1° to about 89° with respect to a remaining portion of the plurality of blades (4).
4. The device of Claim 3, wherein the projection (68) extends out from a plane defined by the at least one blade (4).
6. The device of Claim 4, wherein the projection (68) is a prong (4).
6. The device of Claim 3, wherein the projection is integral with an edge of the at least one blade and in a plane defined by the at least one blade.
7. The device of Claim 1, further comprising a therapeutic agent delivery device (10, 88, 98, 104) connected to the piercing device (2) and positioned to deliver a therapeutic agent through the openings (8) to the body surface, the agent delivery device (10, 88, 98, 104) being selected from the group consisting of an electrotransport device (10), a passive diffusion device (88, 98), an osmotic device (104), and a pressure driven device.
8. The device of Claim 7, wherein the agent comprises a polypeptide or protein.
9. The device of Claim 1, further comprising a sampling device (10, 88, 98, 104) connected to the piercing device (2) and positioned to sample a substance from the body surface through the opening(s) (8), the sampling device being selected from the group consisting of a reverse electrotransport device (10), a passive diffusion device (88, 98), en osmotic device (104), and a negative pressure driven device.
10. The device of Claim 9, wherein the sampled substance is selected from the group consisting of body electrolytes, illicit drugs and glucose.
11. The device of Claim 1, wherein a portion of the plurality of blades (4) are located along a periphery of an opening (8) through the sheet (6).
12. The device of Claim 1, further comprising a plurality of second openings (80) through the sheet (6) being spaced between the plurality of openings (8),
13. The device of Claim 1, wherein the device has about 600 to about 1000 blades/cm2.
14, The device of Claim 1, wherein the device has at least about 800 blades/cm2.
15. The device of Claim 1, wherein at least a portion of the plurality of blades (4) have a length sufficient to pierce the stratum corneum of the body surface to a depth of at least about 25 µm.
16. The device of Claim 1, wherein each of the plurality of blades (4) is oriented approximately perpendicular to the sheet (6).
17. The device of Claim 1, wherein each of the plurality of blades (4) is oriented at an angle in the range of about 1° to about 89° to the sheet (6).
18. The device of Claim 1, wherein each of the plurality of blades (4) is oriented at an angle in the range of about 10° to about 60° to the sheet (6).
19. The device of Claim 1, wherein at least a portion of the plurality of blades (4) have a thickness in the range of about 7 µm to about 100 µm.
20. The device of Claim 1, wherein at least a portion of the plurality of blades (4) have a thickness in the range of about 25 µm to about 50 µm.
21. The device of Claim 1, wherein the plurality of blades (4) is composed of a material selected from the group consisting of metals, metal alloys, glasses, ceramics and rigid polymers.
22. The device of Claim 1, wherein the blades (4) are comprised of photo-etched metal.
23. The device of Claim 1, wherein the plurality of blades (4) are thinner than the sheet (6).
24. A method for producing a device (2) for piercing the stratum corneum of a body surface, the method comprising:
applying a layer of a photo-resist selected from the group consisting of wet resist and dry resist to a first side (49) of a sheet (6);
exposing the layer of photo-resist through a mask pattern for producing a plurality of blades (4);
etching exposed portions of the photo-resist and the sheet (6) to produce the plurality of blades (4) and openings (8) through the sheet (6);
punching the plurality of blades (4) through the openings (8) such that the plurality of blades (4) extend downward from the sheet (6); and incorporating the device (2) for piercing the stratum corneum into a delivery device (14, 88, 98, 104) or a sampling device (10, 88, 98, 104).
25. The method of Claim 24, wherein the etching step comprises spray etching.

31a
26. The method of Claim 24, wherein the punching step comprises:
placing the sheet (6) on a die (52) having a plurality of openings (56) corresponding to the plurality of blades (4) and openings (8) of the sheet (6);
and bending the plurality of blades (4) through the openings (56) to be substantially perpendicular to the sheet (6) with a punch (54) having a plurality of protrusions (58) corresponding to the plurality of openings (56) in the die (52) and the plurality of openings (8) of the sheet (6).
27. A method of transdermally sampling an agent, comprising:
a. placing a device (2) on a body surface through which the agent is to be withdrawn, the device (2) including a sheet (6) having at least one opening (8) therethrough and a plurality of blades (4) extending downward therefrom whereby agent transmitting pathways are formed through the stratum corneum at the body surface, and a reservoir (26, 90, 106) in agent-transmitting relation with the opening (8);
b. withdrawing the agent through the pathways and said opening (8); and c. collecting the agent in the reservoir (26, 90, 106),
28. The method of Claim 27, wherein the sampled agent is selected from the group consisting of body analytes, electrolytes, blood gases, illicit drugs, licit drugs and glucose.
29. The method of Claim 27, further comprising:
connecting a sampling device (10, 88, 98, 104) to a side opposite of a side (48) of the sheet (6) having the blades (4) extending downward therefrom, the sampling device (10, 88, 98, 104) being selected from the group consisting of a reverse electrotransport sampling device (10), a passive sampling device (88, 98), an osmotic sampling device (104), and a negative pressure driven sampling device.
CA002253549A 1996-06-18 1997-06-17 Device for enhancing transdermal agent delivery or sampling Expired - Fee Related CA2253549C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1999096P 1996-06-18 1996-06-18
US60/019,990 1996-06-18
PCT/US1997/010516 WO1997048440A1 (en) 1996-06-18 1997-06-17 Device for enhancing transdermal agent delivery or sampling

Publications (2)

Publication Number Publication Date
CA2253549A1 CA2253549A1 (en) 1997-12-24
CA2253549C true CA2253549C (en) 2005-10-25

Family

ID=21796163

Family Applications (3)

Application Number Title Priority Date Filing Date
CA002253549A Expired - Fee Related CA2253549C (en) 1996-06-18 1997-06-17 Device for enhancing transdermal agent delivery or sampling
CA002253471A Expired - Fee Related CA2253471C (en) 1996-06-18 1997-06-18 Device for enhancing transdermal sampling
CA002257217A Expired - Fee Related CA2257217C (en) 1996-06-18 1997-06-18 Device for enhancing transdermal agent delivery or sampling

Family Applications After (2)

Application Number Title Priority Date Filing Date
CA002253471A Expired - Fee Related CA2253471C (en) 1996-06-18 1997-06-18 Device for enhancing transdermal sampling
CA002257217A Expired - Fee Related CA2257217C (en) 1996-06-18 1997-06-18 Device for enhancing transdermal agent delivery or sampling

Country Status (14)

Country Link
US (5) US6230051B1 (en)
EP (3) EP0914178B1 (en)
JP (4) JP4012252B2 (en)
AR (2) AR008242A1 (en)
AT (3) ATE234129T1 (en)
AU (3) AU3399197A (en)
CA (3) CA2253549C (en)
DE (3) DE69719761T2 (en)
DK (3) DK0914178T3 (en)
ES (3) ES2195151T3 (en)
PT (2) PT917484E (en)
TW (1) TW349872B (en)
WO (3) WO1997048440A1 (en)
ZA (1) ZA975326B (en)

Families Citing this family (738)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04278450A (en) 1991-03-04 1992-10-05 Adam Heller Biosensor and method for analyzing subject
US5593852A (en) 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
AU5869796A (en) * 1995-05-22 1996-12-11 Ned A. Godshall Micromechanical patch for enhancing the delivery of compound s through the skin
US6230051B1 (en) * 1996-06-18 2001-05-08 Alza Corporation Device for enhancing transdermal agent delivery or sampling
US6607509B2 (en) * 1997-12-31 2003-08-19 Medtronic Minimed, Inc. Insertion device for an insertion set and method of using the same
US6918901B1 (en) * 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
ATE221400T1 (en) * 1997-12-11 2002-08-15 Alza Corp DEVICE FOR INCREASE THE TRANSDERMAL FLOW OF ACTIVE INGREDIENTS
KR100557261B1 (en) 1997-12-11 2006-03-07 알자 코포레이션 Device for enhancing transdermal agent flux
DK1037686T3 (en) 1997-12-11 2006-01-02 Alza Corp Apparatus for enhancing transdermal flow of agents
EP1911488A3 (en) 1997-12-11 2008-12-03 Alza Corporation Device for enhancing transdermal agent flux
WO1999040848A1 (en) * 1998-02-17 1999-08-19 Abbott Laboratories Interstitial fluid collection and monitoring device
US6134461A (en) 1998-03-04 2000-10-17 E. Heller & Company Electrochemical analyte
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6757560B1 (en) * 1999-04-09 2004-06-29 Novosis Pharma Ag Transdermal delivery system (TDS) with electrode network
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
CA2332112C (en) * 1998-05-13 2004-02-10 Cygnus, Inc. Monitoring of physiological analytes
US6503231B1 (en) * 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US7922709B2 (en) 1998-07-13 2011-04-12 Genetronics, Inc. Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
US6355021B1 (en) * 1998-07-14 2002-03-12 Maersk Medical A/S Medical puncturing device
DE69937738D1 (en) * 1998-07-21 2008-01-24 Altea Therapeutics Corp METHOD AND DEVICE FOR THE CONTINUOUS MONITORING OF AN ANALYTE
US6532386B2 (en) * 1998-08-31 2003-03-11 Johnson & Johnson Consumer Companies, Inc. Electrotransort device comprising blades
US6148232A (en) * 1998-11-09 2000-11-14 Elecsys Ltd. Transdermal drug delivery and analyte extraction
DE60007290T2 (en) * 1999-01-28 2004-09-23 Cyto Pulse Sciences, Inc. INTRODUCTION OF MACROMOLECULES IN CELLS
DE19903876B4 (en) * 1999-02-01 2006-09-28 Orthogen Gentechnologie Gmbh Process for the in vitro formation and accumulation of interleukin-1 receptor antagonists
US6792306B2 (en) * 2000-03-10 2004-09-14 Biophoretic Therapeutic Systems, Llc Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor
US6856821B2 (en) * 2000-05-26 2005-02-15 Kci Licensing, Inc. System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure
US6743211B1 (en) * 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US6256533B1 (en) * 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
US6379324B1 (en) 1999-06-09 2002-04-30 The Procter & Gamble Company Intracutaneous microneedle array apparatus
US6312612B1 (en) 1999-06-09 2001-11-06 The Procter & Gamble Company Apparatus and method for manufacturing an intracutaneous microneedle array
AU6076200A (en) 1999-07-08 2001-01-30 Johnson & Johnson Consumer Companies, Inc. Exothermic bandage
US6890553B1 (en) 1999-07-08 2005-05-10 Johnson & Johnson Consumer Companies, Inc. Exothermic topical delivery device
US20030078499A1 (en) * 1999-08-12 2003-04-24 Eppstein Jonathan A. Microporation of tissue for delivery of bioactive agents
US7113821B1 (en) 1999-08-25 2006-09-26 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery
US7133717B2 (en) 1999-08-25 2006-11-07 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery and diagnostic sampling
US6251083B1 (en) 1999-09-07 2001-06-26 Amira Medical Interstitial fluid methods and devices for determination of an analyte in the body
US6623457B1 (en) * 1999-09-22 2003-09-23 Becton, Dickinson And Company Method and apparatus for the transdermal administration of a substance
US6835184B1 (en) * 1999-09-24 2004-12-28 Becton, Dickinson And Company Method and device for abrading skin
US6331266B1 (en) 1999-09-29 2001-12-18 Becton Dickinson And Company Process of making a molded device
ATE310561T1 (en) 1999-12-10 2005-12-15 Alza Corp APPARATUS AND METHOD FOR IMPROVING MICRONEEDLE SKIN PIERCING
CA2394171A1 (en) * 1999-12-16 2001-06-21 Alza Corporation Device for enhancing transdermal flux of sampled agents
US20080033492A1 (en) * 2000-01-07 2008-02-07 Biowave Corporation Electro-therapy method
US7013179B2 (en) 2000-01-07 2006-03-14 Biowave Corporation Percutaneous electrode array
EP1164928B1 (en) * 2000-01-21 2005-06-01 Instrumentarium Corporation Method of fabricating a medical electrode
US6622035B1 (en) * 2000-01-21 2003-09-16 Instrumentarium Corp. Electrode for measurement of weak bioelectrical signals
AU781149B2 (en) * 2000-03-17 2005-05-05 Echo Therapeutics, Inc. System, method, and device for non-invasive body fluid sampling and analysis
US7404815B2 (en) * 2000-05-01 2008-07-29 Lifescan, Inc. Tissue ablation by shear force for sampling biological fluids and delivering active agents
US6595947B1 (en) 2000-05-22 2003-07-22 Becton, Dickinson And Company Topical delivery of vaccines
US6565532B1 (en) 2000-07-12 2003-05-20 The Procter & Gamble Company Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup
US6537242B1 (en) 2000-06-06 2003-03-25 Becton, Dickinson And Company Method and apparatus for enhancing penetration of a member for the intradermal sampling or administration of a substance
US6607513B1 (en) 2000-06-08 2003-08-19 Becton, Dickinson And Company Device for withdrawing or administering a substance and method of manufacturing a device
US9717451B2 (en) 2000-06-08 2017-08-01 Becton, Dickinson And Company Device for withdrawing or administering a substance and method of manufacturing a device
US6540675B2 (en) * 2000-06-27 2003-04-01 Rosedale Medical, Inc. Analyte monitor
US6589202B1 (en) 2000-06-29 2003-07-08 Becton Dickinson And Company Method and apparatus for transdermally sampling or administering a substance to a patient
US6603987B2 (en) * 2000-07-11 2003-08-05 Bayer Corporation Hollow microneedle patch
US6440096B1 (en) 2000-07-14 2002-08-27 Becton, Dickinson And Co. Microdevice and method of manufacturing a microdevice
US6656147B1 (en) 2000-07-17 2003-12-02 Becton, Dickinson And Company Method and delivery device for the transdermal administration of a substance
GB0017999D0 (en) 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
US6749575B2 (en) 2001-08-20 2004-06-15 Alza Corporation Method for transdermal nucleic acid sampling
CN1471378A (en) 2000-08-24 2004-01-28 阿尔扎公司 Method for transdermal nucleic acid sampling
US6690959B2 (en) 2000-09-01 2004-02-10 Medtronic, Inc. Skin-mounted electrodes with nano spikes
RU2272618C2 (en) * 2000-09-08 2006-03-27 Алза Корпорейшн Method for inhibiting reduction of transdermal drug movement by inhibiting paths closing
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
WO2002030506A2 (en) 2000-10-12 2002-04-18 Ink Jet Technology Ltd. Transdermal method
NZ525294A (en) * 2000-10-13 2005-02-25 Alza Corp Apparatus and method for piercing skin with microprotrusions
US7419481B2 (en) 2000-10-13 2008-09-02 Alza Corporation Apparatus and method for piercing skin with microprotrusions
CN100391404C (en) 2000-10-13 2008-06-04 阿尔扎公司 Microblade array impact applicator
HUP0303576A2 (en) 2000-10-13 2004-01-28 Alza Corp Microprotrusion member retainer for impact applicator
US6821281B2 (en) 2000-10-16 2004-11-23 The Procter & Gamble Company Microstructures for treating and conditioning skin
US7828827B2 (en) 2002-05-24 2010-11-09 Corium International, Inc. Method of exfoliation of skin using closely-packed microstructures
US7131987B2 (en) * 2000-10-16 2006-11-07 Corium International, Inc. Microstructures and method for treating and conditioning skin which cause less irritation during exfoliation
ES2377077T3 (en) 2000-10-18 2012-03-22 Glaxosmithkline Biologicals S.A. Vaccines comprising the MAGE antigen bound to a protein D fragment
CA2427381A1 (en) 2000-10-26 2002-11-28 Alza Corporation Transdermal drug delivery devices having coated microprotrusions
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
DE10057832C1 (en) * 2000-11-21 2002-02-21 Hartmann Paul Ag Blood analysis device has syringe mounted in casing, annular mounting carrying needles mounted behind test strip and being swiveled so that needle can be pushed through strip and aperture in casing to take blood sample
US6591133B1 (en) * 2000-11-27 2003-07-08 Microlin Llc Apparatus and methods for fluid delivery using electroactive needles and implantable electrochemical delivery devices
WO2002064193A2 (en) * 2000-12-14 2002-08-22 Georgia Tech Research Corporation Microneedle devices and production thereof
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US6663820B2 (en) 2001-03-14 2003-12-16 The Procter & Gamble Company Method of manufacturing microneedle structures using soft lithography and photolithography
US6855372B2 (en) 2001-03-16 2005-02-15 Alza Corporation Method and apparatus for coating skin piercing microprojections
US6932933B2 (en) * 2001-03-30 2005-08-23 The Aerospace Corporation Ultraviolet method of embedding structures in photocerams
US7041468B2 (en) 2001-04-02 2006-05-09 Therasense, Inc. Blood glucose tracking apparatus and methods
DE60233939D1 (en) * 2001-04-20 2009-11-19 Alza Corp MICROPROJECTION ARRANGEMENT WITH A COATING CONTAINING ADVANTAGEOUS MEDIUM
US20020193729A1 (en) * 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method
EP1752189A3 (en) 2001-04-20 2007-02-21 Alza Corporation Microprojection array having a beneficial agent containing coating
US6591124B2 (en) * 2001-05-11 2003-07-08 The Procter & Gamble Company Portable interstitial fluid monitoring system
US6855117B2 (en) 2001-08-01 2005-02-15 Johnson & Johnson Consumer Companies, Inc. Method of treating the skin of a subject
US6790179B2 (en) 2001-08-01 2004-09-14 Johnson & Johnson Consumer Companies, Inc. Method of examining and diagnosing skin health
US6840910B2 (en) 2001-08-01 2005-01-11 Johnson & Johnson Consumer Companies, Inc. Method of distributing skin care products
AU2002312380A1 (en) 2001-06-08 2002-12-23 Becton, Dickinson And Company Device for manipulating a needle or abrader array
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
ATE485766T1 (en) 2001-06-12 2010-11-15 Pelikan Technologies Inc ELECTRICAL ACTUATING ELEMENT FOR A LANCET
WO2002100254A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
US7316700B2 (en) 2001-06-12 2008-01-08 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
WO2002102273A2 (en) * 2001-06-20 2002-12-27 Power Paper Ltd. Adhesive bandage with display
CN1310618C (en) * 2001-07-19 2007-04-18 爱科来株式会社 Piercing device
US20030028087A1 (en) * 2001-08-01 2003-02-06 Yuzhakov Vadim Vladimirovich Devices for analyte concentration determination and methods of using the same
SE0102736D0 (en) * 2001-08-14 2001-08-14 Patrick Griss Side opened out-of-plane microneedles for microfluidic transdermal interfacing and fabrication process of side opened out-of-plane microneedles
US6881203B2 (en) * 2001-09-05 2005-04-19 3M Innovative Properties Company Microneedle arrays and methods of manufacturing the same
AU2002333554C1 (en) 2001-09-12 2008-12-11 Becton, Dickinson And Company Microneedle-based pen device for drug delivery and method for using same
US20040087992A1 (en) * 2002-08-09 2004-05-06 Vladimir Gartstein Microstructures for delivering a composition cutaneously to skin using rotatable structures
WO2003024507A2 (en) * 2001-09-19 2003-03-27 Biovalve Technologies, Inc. Microneedles, microneedle arrays, and systems and methods relating to same
US20070179717A1 (en) * 2001-09-21 2007-08-02 Milliken Gordon L System and method for management of specimens
US6830562B2 (en) * 2001-09-27 2004-12-14 Unomedical A/S Injector device for placing a subcutaneous infusion set
CA2500452A1 (en) * 2001-09-28 2003-04-03 Biovalve Technologies, Inc. Switchable microneedle arrays and systems and methods relating to same
CA2500453A1 (en) * 2001-09-28 2003-04-03 Biovalve Technologies, Inc. Microneedle with membrane
US6689100B2 (en) 2001-10-05 2004-02-10 Becton, Dickinson And Company Microdevice and method of delivering or withdrawing a substance through the skin of an animal
US20030069482A1 (en) * 2001-10-09 2003-04-10 Workman Jerome James Sampling article for determining quantitative and qualitative drug transfer to skin
US6966880B2 (en) * 2001-10-16 2005-11-22 Agilent Technologies, Inc. Universal diagnostic platform
US7429258B2 (en) * 2001-10-26 2008-09-30 Massachusetts Institute Of Technology Microneedle transport device
US20040120964A1 (en) * 2001-10-29 2004-06-24 Mikszta John A. Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses
AU2002367965A1 (en) * 2001-11-06 2003-12-31 Dermal Systems International Inc. High throughput methods and devices for assaying analytes in a fluid sample
AU2002353444A1 (en) * 2001-11-07 2003-05-19 Transpharma Medical Ltd. Integrated transdermal drug delivery system
US20030199810A1 (en) * 2001-11-30 2003-10-23 Trautman Joseph Creagan Methods and apparatuses for forming microprojection arrays
ES2297056T3 (en) * 2001-12-20 2008-05-01 Alza Corporation MICRO-PROJECTIONS FOR SKIN PERFORATION THAT HAVE CONTROL OF THE DEPTH OF DRILLING.
ITTO20011228A1 (en) * 2001-12-28 2003-06-28 Cane Srl DISPOSABLE NEEDLE CONTAINER.
US20040073175A1 (en) * 2002-01-07 2004-04-15 Jacobson James D. Infusion system
US6908453B2 (en) * 2002-01-15 2005-06-21 3M Innovative Properties Company Microneedle devices and methods of manufacture
MXPA04007389A (en) 2002-02-04 2004-10-11 Becton Dickinson Co Device and method for delivering or withdrawing a substance through the skin.
US7004928B2 (en) 2002-02-08 2006-02-28 Rosedale Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
AU2003208296A1 (en) * 2002-02-12 2003-09-04 Unomedial A/S Infusion device with needle shield
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8116860B2 (en) 2002-03-11 2012-02-14 Altea Therapeutics Corporation Transdermal porator and patch system and method for using same
US9918665B2 (en) 2002-03-11 2018-03-20 Nitto Denko Corporation Transdermal porator and patch system and method for using same
EP2319578B1 (en) * 2002-03-11 2016-11-02 Nitto Denko Corporation Transdermal drug delievery patch system, method of making same and method of using same
US7047070B2 (en) * 2002-04-02 2006-05-16 Becton, Dickinson And Company Valved intradermal delivery device and method of intradermally delivering a substance to a patient
US6780171B2 (en) 2002-04-02 2004-08-24 Becton, Dickinson And Company Intradermal delivery device
US7115108B2 (en) 2002-04-02 2006-10-03 Becton, Dickinson And Company Method and device for intradermally delivering a substance
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7892185B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
JP4764626B2 (en) 2002-05-06 2011-09-07 ベクトン・ディキンソン・アンド・カンパニー Method and device for controlling the pharmacokinetics of a drug
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
US20030143113A2 (en) * 2002-05-09 2003-07-31 Lifescan, Inc. Physiological sample collection devices and methods of using the same
US20030211619A1 (en) * 2002-05-09 2003-11-13 Lorin Olson Continuous strip of fluid sampling and testing devices and methods of making, packaging and using the same
US20030212344A1 (en) * 2002-05-09 2003-11-13 Vadim Yuzhakov Physiological sample collection devices and methods of using the same
US7060192B2 (en) * 2002-05-09 2006-06-13 Lifescan, Inc. Methods of fabricating physiological sample collection devices
US6945952B2 (en) 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
KR101323980B1 (en) 2002-07-19 2013-10-30 쓰리엠 이노베이티브 프로퍼티즈 컴파니 Microneedle device, method of using microneedle device and method of delivering microneedle device
TW200409657A (en) * 2002-08-08 2004-06-16 Alza Corp Transdermal vaccine delivery device having coated microprotrusions
WO2004020015A2 (en) 2002-08-29 2004-03-11 Becton Dickinson And Company Microprotrusion arrays and methods for using same to deliver substances into tissue
WO2004020035A1 (en) * 2002-09-02 2004-03-11 Unomedical A/S A device for subcutaneous administration of a medicament to a patient and tubing for same
DK1556124T3 (en) * 2002-09-02 2008-02-18 Unomedical As Apparatus and method for adjusting the length of an infusion tube
US20040051019A1 (en) * 2002-09-02 2004-03-18 Mogensen Lasse Wesseltoft Apparatus for and a method of adjusting the length of an infusion tube
DE60325624D1 (en) * 2002-09-02 2009-02-12 Unomedical As DEVICE FOR THE SUBCUTANEOUS ADMINISTRATION OF A MEDICAMENT TO A PATIENT
US20120296233A9 (en) * 2002-09-05 2012-11-22 Freeman Dominique M Methods and apparatus for an analyte detecting device
AU2003275311A1 (en) * 2002-09-16 2004-04-30 Sung-Yun Kwon Solid micro-perforators and methods of use
US20040236269A1 (en) 2002-09-25 2004-11-25 Marchitto Kevin S. Microsurgical tissue treatment system
WO2004030743A2 (en) * 2002-09-30 2004-04-15 Alza Corporation Drug delivery device having coated microprojections incorporating vasoconstrictors
US7244394B2 (en) * 2002-10-03 2007-07-17 Novartis Ag Methods and kits for assays of analytes of interest in tears
US20040106904A1 (en) * 2002-10-07 2004-06-03 Gonnelli Robert R. Microneedle array patch
DK1575656T3 (en) 2002-10-11 2009-09-14 Becton Dickinson Co Insulin delivery system with sensor
US7381184B2 (en) 2002-11-05 2008-06-03 Abbott Diabetes Care Inc. Sensor inserter assembly
US7045069B2 (en) * 2002-11-14 2006-05-16 Gennady Ozeryansky Microfabrication method based on metal matrix composite technology
DK200201823A (en) 2002-11-26 2004-05-27 Maersk Medical As Connection piece for a hose connection
US7018345B2 (en) * 2002-12-06 2006-03-28 Hisamitsu Pharmaceutical Co., Inc. Iontophoresis system
AR042815A1 (en) * 2002-12-26 2005-07-06 Alza Corp ACTIVE AGENT SUPPLY DEVICE THAT HAS COMPOUND MEMBERS
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
EP1578262A4 (en) 2002-12-31 2007-12-05 Therasense Inc Continuous glucose monitoring system and methods of use
US20040158202A1 (en) * 2003-02-12 2004-08-12 Soren Jensen Cover
US7578954B2 (en) * 2003-02-24 2009-08-25 Corium International, Inc. Method for manufacturing microstructures having multiple microelements with through-holes
US7052652B2 (en) 2003-03-24 2006-05-30 Rosedale Medical, Inc. Analyte concentration detection devices and methods
US20050070819A1 (en) * 2003-03-31 2005-03-31 Rosedale Medical, Inc. Body fluid sampling constructions and techniques
US7070580B2 (en) * 2003-04-01 2006-07-04 Unomedical A/S Infusion device and an adhesive sheet material and a release liner
US20040265351A1 (en) * 2003-04-10 2004-12-30 Miller Richard L. Methods and compositions for enhancing immune response
US7415299B2 (en) * 2003-04-18 2008-08-19 The Regents Of The University Of California Monitoring method and/or apparatus
JP2004343275A (en) * 2003-05-14 2004-12-02 Murata Mach Ltd Image processing system and scanner
ATE476137T1 (en) 2003-05-30 2010-08-15 Pelikan Technologies Inc METHOD AND DEVICE FOR INJECTING LIQUID
WO2004107964A2 (en) 2003-06-06 2004-12-16 Pelikan Technologies, Inc. Blood harvesting device with electronic control
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
EP1638523B8 (en) 2003-06-30 2013-12-25 ALZA Corporation Formulations for coated microprojections containing non-volatile counterions
US20050123507A1 (en) * 2003-06-30 2005-06-09 Mahmoud Ameri Formulations for coated microprojections having controlled solubility
PE20050288A1 (en) * 2003-07-02 2005-04-29 Alza Corp METHOD AND IMMUNIZATION PATCH BY MICROPROJECTION DISPOSAL
EP1648363B1 (en) * 2003-07-03 2019-03-06 Corium International, Inc. Wound dressing, ingredient delivery device and iv hold-down, and method relating to same
US7695239B2 (en) * 2003-07-14 2010-04-13 Fortrend Engineering Corporation End effector gripper arms having corner grippers which reorient reticle during transfer
WO2005007223A2 (en) * 2003-07-16 2005-01-27 Sasha John Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations
US7424318B2 (en) 2003-12-05 2008-09-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US7460898B2 (en) * 2003-12-05 2008-12-02 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US7366556B2 (en) 2003-12-05 2008-04-29 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US7467003B2 (en) * 2003-12-05 2008-12-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US7761130B2 (en) * 2003-07-25 2010-07-20 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US7494465B2 (en) 2004-07-13 2009-02-24 Dexcom, Inc. Transcutaneous analyte sensor
US8160669B2 (en) 2003-08-01 2012-04-17 Dexcom, Inc. Transcutaneous analyte sensor
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
CA2534823A1 (en) * 2003-08-04 2005-02-24 Alza Corporation Method and device for enhancing transdermal agent flux
US7223248B2 (en) * 2003-08-13 2007-05-29 Lifescan, Inc. Packaged medical device with a deployable dermal tissue penetration member
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US20140121989A1 (en) 2003-08-22 2014-05-01 Dexcom, Inc. Systems and methods for processing analyte sensor data
BRPI0413867A (en) * 2003-08-26 2006-10-24 Alza Corp device and method for intradermal cell implantation
US7099968B2 (en) * 2003-09-02 2006-08-29 Intel Corporation System and method for generating bus requests in advance based on speculation states
US8353861B2 (en) * 2003-09-18 2013-01-15 Texmac, Inc. Applicator for applying functional substances into human skin
EP1671096A4 (en) 2003-09-29 2009-09-16 Pelikan Technologies Inc Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
US20050089554A1 (en) * 2003-10-24 2005-04-28 Cormier Michel J. Apparatus and method for enhancing transdermal drug delivery
CN1897898A (en) * 2003-10-24 2007-01-17 阿尔扎公司 Pretreatment method and system for enhancing transdermal drug delivery
US8016811B2 (en) 2003-10-24 2011-09-13 Altea Therapeutics Corporation Method for transdermal delivery of permeant substances
WO2005044139A2 (en) 2003-10-28 2005-05-19 Alza Corporation Method and apparatus for reducing the incidence of tobacco use
AU2004287414B2 (en) 2003-10-31 2010-11-25 Alza Corporation Self-actuating applicator for microprojection array
US7299082B2 (en) 2003-10-31 2007-11-20 Abbott Diabetes Care, Inc. Method of calibrating an analyte-measurement device, and associated methods, devices and systems
USD914881S1 (en) 2003-11-05 2021-03-30 Abbott Diabetes Care Inc. Analyte sensor electronic mount
US20060036209A1 (en) * 2003-11-13 2006-02-16 Janardhanan Subramony System and method for transdermal delivery
DE10353629A1 (en) * 2003-11-17 2005-06-16 Lts Lohmann Therapie-Systeme Ag Device for the transdermal administration of active substances
CA2546443A1 (en) * 2003-11-18 2005-06-02 Nanopass Technologies Ltd. Enhanced penetration system and method for sliding microneedles
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
EP1713533A4 (en) * 2003-11-21 2008-01-23 Univ California Method and/or apparatus for puncturing a surface for extraction, in situ analysis, and/or substance delivery using microneedles
CA2546723A1 (en) * 2003-11-21 2005-06-09 Alza Corporation Ultrasound assisted transdermal vaccine delivery method and system
MXPA06006041A (en) * 2003-11-28 2007-01-31 Acrux Dds Pty Ltd Method and system for rapid transdermal administration.
US8364231B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
EP2239567B1 (en) 2003-12-05 2015-09-02 DexCom, Inc. Calibration techniques for a continuous analyte sensor
US8774886B2 (en) 2006-10-04 2014-07-08 Dexcom, Inc. Analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8017145B2 (en) * 2003-12-22 2011-09-13 Conopco, Inc. Exfoliating personal care wipe article containing an array of projections
EP1706026B1 (en) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
GB0402131D0 (en) 2004-01-30 2004-03-03 Isis Innovation Delivery method
US20080312555A1 (en) * 2004-02-06 2008-12-18 Dirk Boecker Devices and methods for glucose measurement using rechargeable battery energy sources
WO2005089103A2 (en) 2004-02-17 2005-09-29 Therasense, Inc. Method and system for providing data communication in continuous glucose monitoring and management system
JP2007523771A (en) * 2004-02-23 2007-08-23 スリーエム イノベイティブ プロパティズ カンパニー Microneedle array molding method
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
AU2005228145B2 (en) * 2004-03-24 2011-03-03 Corium Pharma Solutions, Inc. Transdermal delivery device
DK1727576T3 (en) 2004-03-26 2009-07-06 Unomedical As Infusion
CA2562642A1 (en) * 2004-04-13 2005-11-03 Alza Corporation Apparatus and method for transdermal delivery of multiple vaccines
WO2006104498A2 (en) * 2004-04-20 2006-10-05 University Of Rochester Hydrogel-supported porous semiconductor devices
MXPA06013168A (en) * 2004-05-13 2007-05-15 Johnson & Johnson Apparatus and method for transdermal delivery of parathyroid hormone agents.
JP2008507590A (en) * 2004-05-19 2008-03-13 アルザ コーポレイション Methods and formulations for transdermal delivery of immunoactive agents
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc Method and apparatus for a fluid sampling device
US7315758B2 (en) 2004-06-03 2008-01-01 Lynntech, Inc. Transdermal delivery of therapeutic agent
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
CA2572455C (en) 2004-06-04 2014-10-28 Therasense, Inc. Diabetes care host-client architecture and data management system
US20050273049A1 (en) * 2004-06-08 2005-12-08 Peter Krulevitch Drug delivery device using microprojections
US20050273075A1 (en) * 2004-06-08 2005-12-08 Peter Krulevitch Method for delivering drugs to the adventitia using device having microprojections
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US20060270922A1 (en) 2004-07-13 2006-11-30 Brauker James H Analyte sensor
US7857760B2 (en) 2004-07-13 2010-12-28 Dexcom, Inc. Analyte sensor
US7310544B2 (en) 2004-07-13 2007-12-18 Dexcom, Inc. Methods and systems for inserting a transcutaneous analyte sensor
US7537590B2 (en) * 2004-07-30 2009-05-26 Microchips, Inc. Multi-reservoir device for transdermal drug delivery and sensing
US20060030811A1 (en) * 2004-08-03 2006-02-09 Wong Patrick S Method and device for enhancing transdermal agent flux
US20060030788A1 (en) * 2004-08-04 2006-02-09 Daniel Wong Apparatus and method for extracting bodily fluid utilizing a flat lancet
US8062250B2 (en) 2004-08-10 2011-11-22 Unomedical A/S Cannula device
US20060058602A1 (en) * 2004-08-17 2006-03-16 Kwiatkowski Krzysztof C Interstitial fluid analyzer
US7798153B2 (en) * 2004-08-23 2010-09-21 Us Smokeless Tobacco Co. Nicotiana Kawakamii smokeless tobacco
TW200626196A (en) * 2004-09-08 2006-08-01 Alza Corp Microprojection array with improved skin adhesion and compliance
EP2305295B1 (en) 2004-09-22 2015-04-01 GlaxoSmithKline Biologicals SA Antibody composition for use in vaccination against staphylococcei
US20060067943A1 (en) * 2004-09-28 2006-03-30 Yuh-Fun Maa Stabilization of alum-adjuvanted immunologically active agents
ITPD20040252A1 (en) * 2004-10-14 2005-01-14 Bidoia Sas Di Gianfranco Bidoi SURGICAL IRRIGATOR
JP4416625B2 (en) * 2004-10-29 2010-02-17 シスメックス株式会社 Tissue cutting device, tissue cutting auxiliary device and storage container
CA2587386C (en) * 2004-11-18 2013-01-15 3M Innovative Properties Company Microneedle array applicator and retainer
JP4927751B2 (en) * 2004-11-18 2012-05-09 スリーエム イノベイティブ プロパティズ カンパニー Microneedle array coating method
KR20130026511A (en) * 2004-11-18 2013-03-13 쓰리엠 이노베이티브 프로퍼티즈 컴파니 Low-profile microneedle array applicator
WO2006055844A2 (en) 2004-11-18 2006-05-26 3M Innovative Properties Company Method of contact coating a microneedle array
US8057842B2 (en) 2004-11-18 2011-11-15 3M Innovative Properties Company Method of contact coating a microneedle array
CN100367906C (en) * 2004-12-08 2008-02-13 圣美迪诺医疗科技(湖州)有限公司 Endermic implantating biological sensors
JP4964141B2 (en) * 2004-12-10 2012-06-27 ウノメディカル アクティーゼルスカブ Insertion tool
CA2594291C (en) * 2004-12-28 2012-03-06 Nabtesco Corporation Skin needle manufacturing apparatus and skin needle manufacturing method
US9398882B2 (en) 2005-09-30 2016-07-26 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor and data processing device
US8571624B2 (en) 2004-12-29 2013-10-29 Abbott Diabetes Care Inc. Method and apparatus for mounting a data transmission device in a communication system
US20090105569A1 (en) 2006-04-28 2009-04-23 Abbott Diabetes Care, Inc. Introducer Assembly and Methods of Use
US9743862B2 (en) 2011-03-31 2017-08-29 Abbott Diabetes Care Inc. Systems and methods for transcutaneously implanting medical devices
US9572534B2 (en) 2010-06-29 2017-02-21 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
US8512243B2 (en) 2005-09-30 2013-08-20 Abbott Diabetes Care Inc. Integrated introducer and transmitter assembly and methods of use
US10226207B2 (en) 2004-12-29 2019-03-12 Abbott Diabetes Care Inc. Sensor inserter having introducer
US7731657B2 (en) 2005-08-30 2010-06-08 Abbott Diabetes Care Inc. Analyte sensor introducer and methods of use
US9259175B2 (en) 2006-10-23 2016-02-16 Abbott Diabetes Care, Inc. Flexible patch for fluid delivery and monitoring body analytes
US8029441B2 (en) 2006-02-28 2011-10-04 Abbott Diabetes Care Inc. Analyte sensor transmitter unit configuration for a data monitoring and management system
US8333714B2 (en) 2006-09-10 2012-12-18 Abbott Diabetes Care Inc. Method and system for providing an integrated analyte sensor insertion device and data processing unit
US7883464B2 (en) 2005-09-30 2011-02-08 Abbott Diabetes Care Inc. Integrated transmitter unit and sensor introducer mechanism and methods of use
US7697967B2 (en) 2005-12-28 2010-04-13 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
US9788771B2 (en) 2006-10-23 2017-10-17 Abbott Diabetes Care Inc. Variable speed sensor insertion devices and methods of use
US20090082693A1 (en) * 2004-12-29 2009-03-26 Therasense, Inc. Method and apparatus for providing temperature sensor module in a data communication system
US9636450B2 (en) 2007-02-19 2017-05-02 Udo Hoss Pump system modular components for delivering medication and analyte sensing at seperate insertion sites
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
EP1846095A4 (en) * 2005-01-20 2014-03-05 Epley Medical Llc Minimally invasive, sustained, intra-tympanic drug delivery system
WO2006089285A1 (en) * 2005-02-16 2006-08-24 Alza Corporation Microprojection arrays with improved biocompatibility
US7985199B2 (en) 2005-03-17 2011-07-26 Unomedical A/S Gateway system
KR20070121731A (en) * 2005-03-21 2007-12-27 우노메디컬 에이/에스 A mounting pad, an adhesive device comprising such mounting pad, and methods of applying such devices to a patient
JP4793806B2 (en) * 2005-03-22 2011-10-12 Tti・エルビュー株式会社 Iontophoresis device
CA2602259A1 (en) * 2005-03-29 2006-10-05 Arkal Medical, Inc. Devices, systems, methods and tools for continuous glucose monitoring
US20060253079A1 (en) * 2005-04-25 2006-11-09 Mcdonough Justin Stratum corneum piercing device
US20070270738A1 (en) * 2005-04-25 2007-11-22 Wu Jeffrey M Method of treating ACNE with stratum corneum piercing patch
US20080009802A1 (en) * 2005-04-25 2008-01-10 Danilo Lambino Method of treating acne with stratum corneum piercing device
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US20060281187A1 (en) 2005-06-13 2006-12-14 Rosedale Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
DK1896097T3 (en) * 2005-06-28 2010-11-22 Unomedical As Packaging for infusion sets and method of using an infusion set
US20070004989A1 (en) * 2005-06-29 2007-01-04 Parvinder Dhillon Device for transdermal sampling
US20070025869A1 (en) * 2005-07-15 2007-02-01 Gordon John H Fluid Delivery Device
US20070078414A1 (en) * 2005-08-05 2007-04-05 Mcallister Devin V Methods and devices for delivering agents across biological barriers
US8386030B2 (en) * 2005-08-08 2013-02-26 Tti Ellebeau, Inc. Iontophoresis device
EP1921980A4 (en) 2005-08-31 2010-03-10 Univ Virginia Improving the accuracy of continuous glucose sensors
CN101687094B (en) * 2005-09-06 2012-09-26 谢拉杰克特股份有限公司 Solid solution perforator containing drug particle and/or drug-adsorbed particles
US9358033B2 (en) * 2005-09-07 2016-06-07 Ulthera, Inc. Fluid-jet dissection system and method for reducing the appearance of cellulite
US8518069B2 (en) 2005-09-07 2013-08-27 Cabochon Aesthetics, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US9011473B2 (en) 2005-09-07 2015-04-21 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US9486274B2 (en) 2005-09-07 2016-11-08 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US10548659B2 (en) 2006-01-17 2020-02-04 Ulthera, Inc. High pressure pre-burst for improved fluid delivery
PL1762259T3 (en) 2005-09-12 2011-03-31 Unomedical As Inserter for an infusion set with a first and second spring units
CN101267896A (en) * 2005-09-12 2008-09-17 阿尔扎公司 Coatable transdermal delivery microprojection assembly
US20070185432A1 (en) * 2005-09-19 2007-08-09 Transport Pharmaceuticals, Inc. Electrokinetic system and method for delivering methotrexate
US20070066934A1 (en) * 2005-09-19 2007-03-22 Transport Pharmaceuticals, Inc. Electrokinetic delivery system and methods therefor
US20090036795A1 (en) * 2005-09-26 2009-02-05 Koninklijke Philips Electronics, N.V. Substance sampling and/or substance delivery via skin
US20070083147A1 (en) * 2005-09-30 2007-04-12 Transcutaneous Technologies Inc. Iontophoresis apparatus and method to deliver antibiotics to biological interfaces
JP2009509659A (en) * 2005-09-30 2009-03-12 Tti・エルビュー株式会社 Iontophoresis device and method for delivery of active agents to biological interfaces
US9521968B2 (en) 2005-09-30 2016-12-20 Abbott Diabetes Care Inc. Analyte sensor retention mechanism and methods of use
US8880138B2 (en) 2005-09-30 2014-11-04 Abbott Diabetes Care Inc. Device for channeling fluid and methods of use
US8801631B2 (en) 2005-09-30 2014-08-12 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
EP1928539A1 (en) * 2005-09-30 2008-06-11 Tti Ellebeau, Inc. Functionalized microneedles transdermal drug delivery systems, devices, and methods
CA2623589C (en) 2005-09-30 2014-07-22 Intuity Medical, Inc. Catalysts for body fluid sample extraction
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7842008B2 (en) 2005-11-21 2010-11-30 Becton, Dickinson And Company Intradermal delivery device
US7885793B2 (en) 2007-05-22 2011-02-08 International Business Machines Corporation Method and system for developing a conceptual model to facilitate generating a business-aligned information technology solution
USD655807S1 (en) 2005-12-09 2012-03-13 Unomedical A/S Medical device
US20070142781A1 (en) * 2005-12-21 2007-06-21 Sayre Chauncey B Microinjector chip
WO2007075614A1 (en) * 2005-12-21 2007-07-05 3M Innovative Properties Company Microneedle devices
NZ569168A (en) 2005-12-22 2012-02-24 Glaxosmithkline Biolog Sa Streptococcus pneumoniae polysaccharide conjugate vaccine comprising 19F-DT conjugate
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
ATE429260T1 (en) 2005-12-23 2009-05-15 Unomedical As ADMINISTRATION DEVICE
EP1968432A4 (en) 2005-12-28 2009-10-21 Abbott Diabetes Care Inc Medical device insertion
US11298058B2 (en) 2005-12-28 2022-04-12 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor insertion
WO2007084247A2 (en) 2005-12-28 2007-07-26 Alza Corporation Stable therapeutic formulations
US7658728B2 (en) * 2006-01-10 2010-02-09 Yuzhakov Vadim V Microneedle array, patch, and applicator for transdermal drug delivery
US7736310B2 (en) 2006-01-30 2010-06-15 Abbott Diabetes Care Inc. On-body medical device securement
ATE532553T1 (en) 2006-02-10 2011-11-15 Hisamitsu Pharmaceutical Co TRANSDERMAL DRUG ADMINISTRATION DEVICE WITH MICRONEEDLES
US7826879B2 (en) 2006-02-28 2010-11-02 Abbott Diabetes Care Inc. Analyte sensors and methods of use
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
NZ570115A (en) 2006-02-28 2010-07-30 Unomedical As Inserter for infusion part and infusion part provided with needle protector
EP1991110B1 (en) * 2006-03-09 2018-11-07 DexCom, Inc. Systems and methods for processing analyte sensor data
WO2007106597A2 (en) * 2006-03-15 2007-09-20 Alza Corporation Method for the transdermal delivery of parathyroid hormone agents for treating osteopenia
US20090131778A1 (en) * 2006-03-28 2009-05-21 Jina Arvind N Devices, systems, methods and tools for continuous glucose monitoring
US20100049021A1 (en) * 2006-03-28 2010-02-25 Jina Arvind N Devices, systems, methods and tools for continuous analyte monitoring
US20080154107A1 (en) * 2006-12-20 2008-06-26 Jina Arvind N Device, systems, methods and tools for continuous glucose monitoring
EA020459B1 (en) 2006-03-30 2014-11-28 Глаксосмитклайн Байолоджикалс С.А. Immunogenic composition
US8224415B2 (en) 2009-01-29 2012-07-17 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US7801582B2 (en) 2006-03-31 2010-09-21 Abbott Diabetes Care Inc. Analyte monitoring and management system and methods therefor
US7618369B2 (en) 2006-10-02 2009-11-17 Abbott Diabetes Care Inc. Method and system for dynamically updating calibration parameters for an analyte sensor
US8374668B1 (en) 2007-10-23 2013-02-12 Abbott Diabetes Care Inc. Analyte sensor with lag compensation
US9392969B2 (en) 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US9326709B2 (en) 2010-03-10 2016-05-03 Abbott Diabetes Care Inc. Systems, devices and methods for managing glucose levels
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US8473022B2 (en) 2008-01-31 2013-06-25 Abbott Diabetes Care Inc. Analyte sensor with time lag compensation
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US9675290B2 (en) 2012-10-30 2017-06-13 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US8346335B2 (en) 2008-03-28 2013-01-01 Abbott Diabetes Care Inc. Analyte sensor calibration management
US8219173B2 (en) 2008-09-30 2012-07-10 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US7630748B2 (en) 2006-10-25 2009-12-08 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US8140312B2 (en) 2007-05-14 2012-03-20 Abbott Diabetes Care Inc. Method and system for determining analyte levels
US7653425B2 (en) 2006-08-09 2010-01-26 Abbott Diabetes Care Inc. Method and system for providing calibration of an analyte sensor in an analyte monitoring system
JP5049268B2 (en) 2006-04-07 2012-10-17 久光製薬株式会社 Microneedle device and transdermal drug administration device with microneedle
WO2007124411A1 (en) * 2006-04-20 2007-11-01 3M Innovative Properties Company Device for applying a microneedle array
AU2007244831A1 (en) * 2006-04-25 2007-11-08 Alza Corporation Microprojection array application with sculptured microprojections for high drug loading
WO2007127811A2 (en) * 2006-04-25 2007-11-08 Alza Corporation Microprojection array application with grouped microprojections for high drug loading
US20070299388A1 (en) * 2006-04-25 2007-12-27 Alza Corporation Microprojection array application with multilayered microprojection member for high drug loading
EP2023818A2 (en) 2006-06-07 2009-02-18 Unomedical A/S Inserter for transcutaneous sensor
US20080071158A1 (en) 2006-06-07 2008-03-20 Abbott Diabetes Care, Inc. Analyte monitoring system and method
CN101489604B (en) 2006-06-09 2012-05-23 优诺医疗有限公司 Mounting pad
US20080015494A1 (en) * 2006-07-11 2008-01-17 Microchips, Inc. Multi-reservoir pump device for dialysis, biosensing, or delivery of substances
CN101500627B (en) 2006-08-02 2012-03-14 优诺医疗有限公司 Cannula and delivery device
JP2010502267A (en) * 2006-08-28 2010-01-28 エージェンシー・フォー・サイエンス・テクノロジー・アンド・リサーチ Microneedle and method for producing microneedle
CA2661912A1 (en) * 2006-08-29 2008-03-06 Alza Corporation Drug electrotransport with hydration measurement of hydratable reservoir
US20080058726A1 (en) * 2006-08-30 2008-03-06 Arvind Jina Methods and Apparatus Incorporating a Surface Penetration Device
US8192474B2 (en) 2006-09-26 2012-06-05 Zeltiq Aesthetics, Inc. Tissue treatment methods
US9132031B2 (en) 2006-09-26 2015-09-15 Zeltiq Aesthetics, Inc. Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
US7831287B2 (en) * 2006-10-04 2010-11-09 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
ES2397714T3 (en) 2006-10-12 2013-03-08 Glaxosmithkline Biologicals S.A. Vaccine comprising an oil-in-water emulsion adjuvant
EP2433648A3 (en) 2006-10-12 2012-04-04 GlaxoSmithKline Biologicals S.A. Vaccine comprising an oil in water emulsion adjuvant
CA2667639A1 (en) 2006-10-26 2008-05-02 Abbott Diabetes Care Inc. Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors
EP1917990A1 (en) 2006-10-31 2008-05-07 Unomedical A/S Infusion set
US8332028B2 (en) * 2006-11-28 2012-12-11 Polyplus Battery Company Protected lithium electrodes for electro-transport drug delivery
US7785301B2 (en) * 2006-11-28 2010-08-31 Vadim V Yuzhakov Tissue conforming microneedle array and patch for transdermal drug delivery or biological fluid collection
US20080147186A1 (en) * 2006-12-14 2008-06-19 Joshi Ashok V Electrochemical Implant For Delivering Beneficial Agents
ES2618838T3 (en) * 2007-01-22 2017-06-22 Nitto Denko Corporation Transdermal pore formation system and patch system
AU2008209537B2 (en) * 2007-01-22 2013-01-31 Corium Pharma Solutions, Inc. Applicators for microneedle arrays
US8121857B2 (en) 2007-02-15 2012-02-21 Abbott Diabetes Care Inc. Device and method for automatic data acquisition and/or detection
US20080199894A1 (en) 2007-02-15 2008-08-21 Abbott Diabetes Care, Inc. Device and method for automatic data acquisition and/or detection
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US20080234562A1 (en) * 2007-03-19 2008-09-25 Jina Arvind N Continuous analyte monitor with multi-point self-calibration
WO2008130895A2 (en) 2007-04-14 2008-10-30 Abbott Diabetes Care, Inc. Method and apparatus for providing dynamic multi-stage signal amplification in a medical device
WO2008130896A1 (en) 2007-04-14 2008-10-30 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in medical communication system
EP4108162A1 (en) 2007-04-14 2022-12-28 Abbott Diabetes Care, Inc. Method and apparatus for providing data processing and control in medical communication system
EP2146625B1 (en) 2007-04-14 2019-08-14 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US9615780B2 (en) 2007-04-14 2017-04-11 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
US8140142B2 (en) 2007-04-14 2012-03-20 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in medical communication system
ES2817249T3 (en) 2007-04-16 2021-04-06 Corium Inc Microneedle matrices obtained by dissolution and casting containing an active principle
US8439861B2 (en) 2007-04-24 2013-05-14 Velcro Industries B.V. Skin penetrating touch fasteners
US8747872B2 (en) 2007-05-02 2014-06-10 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7996158B2 (en) 2007-05-14 2011-08-09 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8103471B2 (en) 2007-05-14 2012-01-24 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8600681B2 (en) 2007-05-14 2013-12-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US10002233B2 (en) 2007-05-14 2018-06-19 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8444560B2 (en) 2007-05-14 2013-05-21 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8239166B2 (en) 2007-05-14 2012-08-07 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8560038B2 (en) 2007-05-14 2013-10-15 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8260558B2 (en) 2007-05-14 2012-09-04 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US9125548B2 (en) 2007-05-14 2015-09-08 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US20080287839A1 (en) 2007-05-18 2008-11-20 Juniper Medical, Inc. Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator
WO2008150917A1 (en) * 2007-05-31 2008-12-11 Abbott Diabetes Care, Inc. Insertion devices and methods
EP2152350A4 (en) 2007-06-08 2013-03-27 Dexcom Inc Integrated medicament delivery device for use with continuous analyte sensor
US20080312518A1 (en) * 2007-06-14 2008-12-18 Arkal Medical, Inc On-demand analyte monitor and method of use
DE202008017390U1 (en) 2007-06-20 2009-08-13 Unomedical A/S Catheter and device for making such a catheter
EP3533387A3 (en) 2007-06-21 2019-11-13 Abbott Diabetes Care, Inc. Health management devices and methods
CA2690870C (en) 2007-06-21 2017-07-11 Abbott Diabetes Care Inc. Health monitor
BRPI0813307C1 (en) 2007-06-26 2021-05-25 Glaxosmithkline Biologicals Sa immunogenic composition, vaccine, and, process to manufacture the vaccine
WO2009006349A2 (en) * 2007-06-29 2009-01-08 Polyplus Battery Company Electrotransport devices, methods and drug electrode assemblies
US8160900B2 (en) 2007-06-29 2012-04-17 Abbott Diabetes Care Inc. Analyte monitoring and management device and method to analyze the frequency of user interaction with the device
WO2009004026A1 (en) 2007-07-03 2009-01-08 Unomedical A/S Inserter having bistable equilibrium states
RU2010104457A (en) 2007-07-10 2011-08-20 Уномедикал А/С (Dk) TWO SPRING INPUT DEVICE
US8523927B2 (en) 2007-07-13 2013-09-03 Zeltiq Aesthetics, Inc. System for treating lipid-rich regions
RU2010105684A (en) 2007-07-18 2011-08-27 Уномедикал А/С (Dk) TURNING INTRODUCTION DEVICE
US8834366B2 (en) 2007-07-31 2014-09-16 Abbott Diabetes Care Inc. Method and apparatus for providing analyte sensor calibration
US7768386B2 (en) * 2007-07-31 2010-08-03 Abbott Diabetes Care Inc. Method and apparatus for providing data processing and control in a medical communication system
US8366677B2 (en) * 2007-08-06 2013-02-05 Transderm, Inc. Microneedle arrays formed from polymer films
EP2197532A1 (en) * 2007-08-06 2010-06-23 Serenity Pharmaceuticals Corporation Methods and devices for desmopressin drug delivery
US8285390B2 (en) 2007-08-21 2012-10-09 Zeltiq Aesthetics, Inc. Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue
US20090069740A1 (en) * 2007-09-07 2009-03-12 Polyplus Battery Company Protected donor electrodes for electro-transport drug delivery
DK2205169T3 (en) * 2007-09-28 2017-02-20 The Queen's Univ Of Belfast Device and method of conveyance
EP2227132B1 (en) 2007-10-09 2023-03-08 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
US8439940B2 (en) 2010-12-22 2013-05-14 Cabochon Aesthetics, Inc. Dissection handpiece with aspiration means for reducing the appearance of cellulite
WO2009048607A1 (en) 2007-10-10 2009-04-16 Corium International, Inc. Vaccine delivery via microneedle arrays
JP5178132B2 (en) * 2007-10-11 2013-04-10 キヤノン株式会社 Image processing system and image processing method
US20090099427A1 (en) * 2007-10-12 2009-04-16 Arkal Medical, Inc. Microneedle array with diverse needle configurations
US8409093B2 (en) 2007-10-23 2013-04-02 Abbott Diabetes Care Inc. Assessing measures of glycemic variability
US8216138B1 (en) 2007-10-23 2012-07-10 Abbott Diabetes Care Inc. Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
US8377031B2 (en) 2007-10-23 2013-02-19 Abbott Diabetes Care Inc. Closed loop control system with safety parameters and methods
US20090164239A1 (en) 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Dynamic Display Of Glucose Information
WO2009079712A1 (en) 2007-12-24 2009-07-02 The University Of Queensland Coating method
US7766846B2 (en) 2008-01-28 2010-08-03 Roche Diagnostics Operations, Inc. Rapid blood expression and sampling
EP2247527A4 (en) 2008-02-07 2014-10-29 Univ Queensland Patch production
NZ587111A (en) 2008-02-13 2012-03-30 Unomedical As Infusion part including seal between cannula and fluid inlet or outlet
US8157747B2 (en) * 2008-02-15 2012-04-17 Lary Research & Development, Llc Single-use indicator for a surgical instrument and a surgical instrument incorporating same
AU2009216703A1 (en) 2008-02-20 2009-08-27 Unomedical A/S Insertion device with horizontally moving part
US20110251602A1 (en) * 2008-04-01 2011-10-13 The General Hospital Corporation Method and apparatus for tissue expansion
US20090259176A1 (en) * 2008-04-09 2009-10-15 Los Gatos Research, Inc. Transdermal patch system
EP3659628A1 (en) 2008-04-10 2020-06-03 Abbott Diabetes Care, Inc. Method and system for sterilizing an analyte sensor
EP2265324B1 (en) 2008-04-11 2015-01-28 Sanofi-Aventis Deutschland GmbH Integrated analyte measurement system
ES2553113T3 (en) 2008-04-16 2015-12-04 Glaxosmithkline Biologicals S.A. Vaccine
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
CN102105108B (en) * 2008-05-21 2013-12-04 谢拉杰克特股份有限公司 Method of manufacturing solid solution peforator patches and uses thereof
HUE046050T2 (en) * 2008-05-21 2020-01-28 Ferring Bv Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
CA2760680A1 (en) 2008-05-23 2009-11-26 The University Of Queensland Analyte detection by microneedle patch with analyte selective reagents
WO2009145920A1 (en) 2008-05-30 2009-12-03 Intuity Medical, Inc. Body fluid sampling device -- sampling site interface
US8591410B2 (en) 2008-05-30 2013-11-26 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
US7826382B2 (en) 2008-05-30 2010-11-02 Abbott Diabetes Care Inc. Close proximity communication device and methods
US8924159B2 (en) 2008-05-30 2014-12-30 Abbott Diabetes Care Inc. Method and apparatus for providing glycemic control
WO2009149308A2 (en) * 2008-06-04 2009-12-10 Seventh Sense Biosystems, Inc. Compositions and methods for rapid one-step diagnosis
JP5642066B2 (en) 2008-06-06 2014-12-17 インテュイティ メディカル インコーポレイテッド Method and apparatus for performing an assay to determine the presence or concentration of an analyte contained in a sample of body fluid
ES2907152T3 (en) 2008-06-06 2022-04-22 Intuity Medical Inc Blood glucose meter and method of operation
US8996104B2 (en) * 2008-06-25 2015-03-31 Fe3 Medical, Inc. Patches and method for the transdermal delivery of a therapeutically effective amount of iron
US8876755B2 (en) 2008-07-14 2014-11-04 Abbott Diabetes Care Inc. Closed loop control system interface and methods
US8202531B2 (en) * 2008-07-23 2012-06-19 Warsaw Orthopedic, Inc. Drug depots having one or more anchoring members
EP2149957B1 (en) * 2008-07-30 2017-06-14 Harman Becker Automotive Systems GmbH Priority based power distribution arrangement
US20100057040A1 (en) 2008-08-31 2010-03-04 Abbott Diabetes Care, Inc. Robust Closed Loop Control And Methods
US9943644B2 (en) 2008-08-31 2018-04-17 Abbott Diabetes Care Inc. Closed loop control with reference measurement and methods thereof
US8622988B2 (en) 2008-08-31 2014-01-07 Abbott Diabetes Care Inc. Variable rate closed loop control and methods
US8734422B2 (en) 2008-08-31 2014-05-27 Abbott Diabetes Care Inc. Closed loop control with improved alarm functions
US10383985B2 (en) * 2008-09-09 2019-08-20 Oxyband Technologies, Inc. Methods and apparatus for charging and evacuating a diffusion dressing
US20100092526A1 (en) 2008-09-26 2010-04-15 Nanobio Corporation Nanoemulsion therapeutic compositions and methods of using the same
US8986208B2 (en) 2008-09-30 2015-03-24 Abbott Diabetes Care Inc. Analyte sensor sensitivity attenuation mitigation
US9326707B2 (en) 2008-11-10 2016-05-03 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
WO2010057197A1 (en) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same
US8603073B2 (en) 2008-12-17 2013-12-10 Zeltiq Aesthetics, Inc. Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
KR20110127642A (en) 2008-12-22 2011-11-25 우노메디컬 에이/에스 Medical device comprising adhesive pad
CA2944660A1 (en) * 2008-12-30 2010-07-08 Teva Pharmaceuticals International Gmbh Electronic control of drug delivery system
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US9402544B2 (en) 2009-02-03 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor and apparatus for insertion of the sensor
WO2012018486A2 (en) 2010-07-26 2012-02-09 Seventh Sense Biosystems, Inc. Rapid delivery and/or receiving of fluids
US20110172510A1 (en) * 2010-01-13 2011-07-14 Seventh Sense Biosystems, Inc. Rapid delivery and/or withdrawal of fluids
US20110105951A1 (en) * 2009-10-30 2011-05-05 Seventh Sense Biosystems, Inc. Systems and methods for treating, sanitizing, and/or shielding the skin or devices applied to the skin
CN102405015B (en) * 2009-03-02 2017-01-18 第七感生物系统有限公司 Devices and methods for the analysis of an extractable medium
US9295417B2 (en) 2011-04-29 2016-03-29 Seventh Sense Biosystems, Inc. Systems and methods for collecting fluid from a subject
US9041541B2 (en) 2010-01-28 2015-05-26 Seventh Sense Biosystems, Inc. Monitoring or feedback systems and methods
US20110172508A1 (en) * 2010-01-13 2011-07-14 Seventh Sense Biosystems, Inc. Sampling device interfaces
US9033898B2 (en) 2010-06-23 2015-05-19 Seventh Sense Biosystems, Inc. Sampling devices and methods involving relatively little pain
JP5563652B2 (en) 2009-03-17 2014-07-30 カーディオスライヴ インコーポレイテッド External defibrillator
US8781576B2 (en) * 2009-03-17 2014-07-15 Cardiothrive, Inc. Device and method for reducing patient transthoracic impedance for the purpose of delivering a therapeutic current
US8617487B2 (en) 2009-03-25 2013-12-31 Venture Lending & Leasing Vi, Inc. Saliva sample collection systems
CN101829396B (en) * 2009-03-27 2013-01-30 清华大学 Micro-needle array chip and percutaneous administration patch using same and preparation method thereof
US8497777B2 (en) 2009-04-15 2013-07-30 Abbott Diabetes Care Inc. Analyte monitoring system having an alert
WO2010121229A1 (en) 2009-04-16 2010-10-21 Abbott Diabetes Care Inc. Analyte sensor calibration management
ES2634667T3 (en) * 2009-04-24 2017-09-28 Corium International, Inc. Methods for manufacturing microprojection assemblies
US8821945B2 (en) 2009-04-25 2014-09-02 Fe3 Medical, Inc. Method for transdermal iontophoretic delivery of chelated agents
WO2010127050A1 (en) 2009-04-28 2010-11-04 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
US8483967B2 (en) 2009-04-29 2013-07-09 Abbott Diabetes Care Inc. Method and system for providing real time analyte sensor calibration with retrospective backfill
US8368556B2 (en) 2009-04-29 2013-02-05 Abbott Diabetes Care Inc. Method and system for providing data communication in continuous glucose monitoring and management system
GB2469839B (en) * 2009-04-29 2014-09-10 Cook Medical Technologies Llc Medical instrument
KR101871659B1 (en) 2009-04-30 2018-08-02 젤티크 애스세틱스, 인코포레이티드. Device, system and method of removing heat from subcutaneous lipid-rich cells
WO2010138856A1 (en) 2009-05-29 2010-12-02 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
US8666466B2 (en) * 2009-06-10 2014-03-04 Medtronic, Inc. Device and method for monitoring of absolute oxygen saturation and tissue hemoglobin concentration
CA2765511C (en) 2009-06-16 2015-05-12 The Regents Of The University Of Michigan Nanoemulsion vaccines
US8613892B2 (en) 2009-06-30 2013-12-24 Abbott Diabetes Care Inc. Analyte meter with a moveable head and methods of using the same
EP3689237B1 (en) 2009-07-23 2021-05-19 Abbott Diabetes Care, Inc. Method of manufacturing and system for continuous analyte measurement
KR20120054598A (en) 2009-07-30 2012-05-30 우노메디컬 에이/에스 Inserter device with horizontal moving part
WO2011014851A1 (en) 2009-07-31 2011-02-03 Abbott Diabetes Care Inc. Method and apparatus for providing analyte monitoring system calibration accuracy
GB0913681D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition
US11096708B2 (en) 2009-08-07 2021-08-24 Ulthera, Inc. Devices and methods for performing subcutaneous surgery
US9358064B2 (en) 2009-08-07 2016-06-07 Ulthera, Inc. Handpiece and methods for performing subcutaneous surgery
CA2766961A1 (en) 2009-08-07 2011-02-10 Unomedical A/S Delivery device with sensor and one or more cannulas
US8993331B2 (en) 2009-08-31 2015-03-31 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
EP2473098A4 (en) 2009-08-31 2014-04-09 Abbott Diabetes Care Inc Analyte signal processing device and methods
CN102473276B (en) 2009-08-31 2016-04-13 雅培糖尿病护理公司 Medical treatment device and method
ES2952361T3 (en) 2009-08-31 2023-10-31 Abbott Diabetes Care Inc Displays for a medical device
US20130018279A1 (en) * 2009-09-01 2013-01-17 Pathway Genomics "blood sample collection apparatus and kits"
WO2011041469A1 (en) 2009-09-29 2011-04-07 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
WO2011041531A1 (en) 2009-09-30 2011-04-07 Abbott Diabetes Care Inc. Interconnect for on-body analyte monitoring device
WO2011053787A2 (en) * 2009-10-30 2011-05-05 Seventh Sense Biosystems, Inc. Systems and methods for application to skin and control of actuation, delivery and/or perception thereof
EP2494323A4 (en) 2009-10-30 2014-07-16 Abbott Diabetes Care Inc Method and apparatus for detecting false hypoglycemic conditions
WO2011065972A2 (en) * 2009-11-24 2011-06-03 Seventh Sense Biosystems, Inc. Patient-enacted sampling technique
EP2506768B1 (en) 2009-11-30 2016-07-06 Intuity Medical, Inc. Calibration material delivery devices and methods
WO2011091431A1 (en) 2010-01-25 2011-07-28 Zeltiq Aesthetics, Inc. Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associated devices, systems and methods
USD924406S1 (en) 2010-02-01 2021-07-06 Abbott Diabetes Care Inc. Analyte sensor inserter
GB201003920D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
GB201003922D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Conjugation process
WO2011162843A1 (en) 2010-03-24 2011-12-29 Abbott Diabetes Care Inc. Medical device inserters and processes of inserting and using medical devices
BR112012024635A2 (en) 2010-03-30 2017-08-08 Unomedical As medical device
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
KR101952155B1 (en) * 2010-04-28 2019-02-26 이노비오 파마수티컬즈, 인크. Oral mucosal electroporation device and use thereof
ES2719595T3 (en) 2010-05-04 2019-07-11 Corium Int Inc Method and device for transdermal administration of parathyroid hormone using a microprojection matrix
US8658603B2 (en) 2010-06-16 2014-02-25 The Regents Of The University Of Michigan Compositions and methods for inducing an immune response
US8635046B2 (en) 2010-06-23 2014-01-21 Abbott Diabetes Care Inc. Method and system for evaluating analyte sensor response characteristics
EP2584964B1 (en) 2010-06-25 2021-08-04 Intuity Medical, Inc. Analyte monitoring devices
US10092229B2 (en) 2010-06-29 2018-10-09 Abbott Diabetes Care Inc. Calibration of analyte measurement system
US11064921B2 (en) 2010-06-29 2021-07-20 Abbott Diabetes Care Inc. Devices, systems and methods for on-skin or on-body mounting of medical devices
WO2012006677A1 (en) 2010-07-14 2012-01-19 The University Of Queensland Patch applying apparatus
CN103068308B (en) 2010-07-16 2016-03-16 第七感生物系统有限公司 For the lower pressure environment of fluid conveying device
US8676338B2 (en) 2010-07-20 2014-03-18 Zeltiq Aesthetics, Inc. Combined modality treatment systems, methods and apparatus for body contouring applications
US20120039809A1 (en) 2010-08-13 2012-02-16 Seventh Sense Biosystems, Inc. Systems and techniques for monitoring subjects
EP2603256B1 (en) * 2010-08-13 2015-07-22 Seventh Sense Biosystems, Inc. Clinical and/or consumer techniques and devices
EP2433663A1 (en) 2010-09-27 2012-03-28 Unomedical A/S Insertion system
EP2436412A1 (en) 2010-10-04 2012-04-04 Unomedical A/S A sprinkler cannula
EP2624745A4 (en) 2010-10-07 2018-05-23 Abbott Diabetes Care, Inc. Analyte monitoring devices and methods
US10024510B2 (en) * 2010-10-26 2018-07-17 Steven G. Hammond Flexible light emitting diode lighting process and assembly
US8808202B2 (en) 2010-11-09 2014-08-19 Seventh Sense Biosystems, Inc. Systems and interfaces for blood sampling
WO2012103242A1 (en) 2011-01-25 2012-08-02 Zeltiq Aesthetics, Inc. Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells
CA3177983A1 (en) 2011-02-28 2012-11-15 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
US10136845B2 (en) 2011-02-28 2018-11-27 Abbott Diabetes Care Inc. Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same
GB201103836D0 (en) 2011-03-07 2011-04-20 Glaxosmithkline Biolog Sa Conjugation process
WO2012142502A2 (en) 2011-04-15 2012-10-18 Dexcom Inc. Advanced analyte sensor calibration and error detection
CN103874461B (en) 2011-04-29 2017-05-10 第七感生物系统有限公司 Devices for collection and/or manipulation of blood spots or other bodily fluids
AU2012249692A1 (en) 2011-04-29 2013-11-14 Seventh Sense Biosystems, Inc. Delivering and/or receiving fluids
US20130158468A1 (en) 2011-12-19 2013-06-20 Seventh Sense Biosystems, Inc. Delivering and/or receiving material with respect to a subject surface
CN103533953A (en) 2011-05-17 2014-01-22 葛兰素史密丝克莱恩生物有限公司 Vaccine against streptococcus pneumoniae
EP4339613A2 (en) 2011-08-03 2024-03-20 Intuity Medical, Inc. Body fluid sampling arrangement
WO2013050277A1 (en) 2011-10-05 2013-04-11 Unomedical A/S Inserter for simultaneous insertion of multiple transcutaneous parts
US11179553B2 (en) 2011-10-12 2021-11-23 Vaxxas Pty Limited Delivery device
CA2851606C (en) 2011-10-12 2020-08-04 3M Innovative Properties Company Integrated microneedle array delivery system
US8585721B2 (en) * 2011-10-12 2013-11-19 Covidien Lp Mesh fixation system
EP2583715A1 (en) 2011-10-19 2013-04-24 Unomedical A/S Infusion tube system and method for manufacture
US9440051B2 (en) 2011-10-27 2016-09-13 Unomedical A/S Inserter for a multiplicity of subcutaneous parts
US9622691B2 (en) 2011-10-31 2017-04-18 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
WO2013066873A1 (en) 2011-10-31 2013-05-10 Abbott Diabetes Care Inc. Electronic devices having integrated reset systems and methods thereof
WO2013070794A2 (en) 2011-11-07 2013-05-16 Abbott Diabetes Care Inc. Analyte monitoring device and methods
US9317656B2 (en) 2011-11-23 2016-04-19 Abbott Diabetes Care Inc. Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof
US8710993B2 (en) 2011-11-23 2014-04-29 Abbott Diabetes Care Inc. Mitigating single point failure of devices in an analyte monitoring system and methods thereof
WO2013078426A2 (en) 2011-11-25 2013-05-30 Abbott Diabetes Care Inc. Analyte monitoring system and methods of use
US9402570B2 (en) 2011-12-11 2016-08-02 Abbott Diabetes Care Inc. Analyte sensor devices, connections, and methods
US20150157840A1 (en) * 2012-06-12 2015-06-11 Hisamitsu Pharmaceutical Co., Inc. Microneedle Sheet
US10132793B2 (en) 2012-08-30 2018-11-20 Abbott Diabetes Care Inc. Dropout detection in continuous analyte monitoring data during data excursions
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
EP2901153A4 (en) 2012-09-26 2016-04-27 Abbott Diabetes Care Inc Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
US20160128947A1 (en) * 2012-10-22 2016-05-12 Stc. Unm Bioadhesive films for local and/or systemic delivery
PL2912186T3 (en) 2012-10-24 2021-06-14 Platelet Targeted Therapeutics Llc Platelet targeted treatment
CA2896188C (en) 2012-12-21 2021-02-23 Corium International, Inc. Microarray for delivery of therapeutic agent and methods of use
BR112015019440A8 (en) 2013-02-20 2019-11-12 Cytrellis Biosystems Inc adjustable dressing, kit, use and method for skin strengthening
AU2014249471B2 (en) 2013-03-12 2019-01-24 Corium Pharma Solutions, Inc. Microprojection applicators
US9844460B2 (en) 2013-03-14 2017-12-19 Zeltiq Aesthetics, Inc. Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same
US9545523B2 (en) 2013-03-14 2017-01-17 Zeltiq Aesthetics, Inc. Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue
MX2015012933A (en) 2013-03-15 2016-09-19 Corium Int Inc Microarray for delivery of therapeutic agent and methods of use.
CA2903763C (en) 2013-03-15 2021-11-16 Corium International, Inc. Microarray with polymer-free microstructures, methods of making, and methods of use
US9474475B1 (en) 2013-03-15 2016-10-25 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
JP2016512754A (en) 2013-03-15 2016-05-09 コリウム インターナショナル, インコーポレイテッド Microarray, method of use and manufacturing for delivery of therapeutic agents
ES2921174T3 (en) 2013-03-15 2022-08-19 Corium Inc Set of microstructures for the delivery of active agents, method of manufacturing the set of microstructures and liquid formulation thereof
US10076285B2 (en) 2013-03-15 2018-09-18 Abbott Diabetes Care Inc. Sensor fault detection using analyte sensor data pattern comparison
US10433773B1 (en) 2013-03-15 2019-10-08 Abbott Diabetes Care Inc. Noise rejection methods and apparatus for sparsely sampled analyte sensor data
ES2939317T3 (en) 2013-03-15 2023-04-20 Corium Pharma Solutions Inc Multi-impact micro-spray applicators
US9907970B2 (en) 2013-06-14 2018-03-06 Cardiothrive, Inc. Therapeutic system and method using biphasic or multiphasic pulse waveform
US9616243B2 (en) 2013-06-14 2017-04-11 Cardiothrive, Inc. Dynamically adjustable multiphasic defibrillator pulse system and method
US10279189B2 (en) 2013-06-14 2019-05-07 Cardiothrive, Inc. Wearable multiphasic cardioverter defibrillator system and method
US9833630B2 (en) 2013-06-14 2017-12-05 Cardiothrive, Inc. Biphasic or multiphasic pulse waveform and method
US10149973B2 (en) 2013-06-14 2018-12-11 Cardiothrive, Inc. Multipart non-uniform patient contact interface and method of use
US9656094B2 (en) 2013-06-14 2017-05-23 Cardiothrive, Inc. Biphasic or multiphasic pulse generator and method
JP2016522070A (en) 2013-06-21 2016-07-28 インテュイティ メディカル インコーポレイテッド Analyte monitoring system using audible feedback
US20150038897A1 (en) 2013-07-30 2015-02-05 Zosano Pharma, Inc. Low-Profile Microneedle Patch Applicator
KR102349218B1 (en) 2013-08-09 2022-01-10 사이트렐리스 바이오시스템즈, 인크. Methods and apparatuses for skin treatment using non-thermal tissue ablation
CN107157479A (en) 2013-08-27 2017-09-15 哈洛纽罗公司 Electrode system for electro photoluminescence
US9782585B2 (en) 2013-08-27 2017-10-10 Halo Neuro, Inc. Method and system for providing electrical stimulation to a user
EP3038700B1 (en) 2013-08-27 2020-03-11 Halo Neuro, Inc. Method and system for providing electrical stimulation to a user
US9486618B2 (en) 2013-08-27 2016-11-08 Halo Neuro, Inc. Electrode system for electrical stimulation
WO2015033959A1 (en) * 2013-09-06 2015-03-12 久光製薬株式会社 Micro-needle sheet
DE102013219432A1 (en) * 2013-09-26 2015-03-26 Peter Röhr Blood collection device and method for withdrawing blood
US10208102B2 (en) 2013-11-01 2019-02-19 University Of Oslo Albumin variants and uses thereof
CA2929126C (en) 2013-11-13 2020-01-07 University Of Oslo Outer membrane vesicles and uses thereof
EP3069138B1 (en) 2013-11-15 2019-01-09 Oslo Universitetssykehus HF Ctl peptide epitopes and antigen-specific t cells, methods for their discovery, and uses thereof
EP3082897A4 (en) 2013-12-19 2017-07-26 Cytrellis Biosystems, Inc. Methods and devices for manipulating subdermal fat
CA2933166C (en) 2013-12-31 2020-10-27 Abbott Diabetes Care Inc. Self-powered analyte sensor and devices using the same
TWI548395B (en) * 2014-01-28 2016-09-11 微凸科技股份有限公司 Transdermal micrneedles continuous monitoring system
EP3099259A1 (en) 2014-01-31 2016-12-07 Zeltiq Aesthetics, Inc. Treatment systems and methods for affecting glands and other targeted structures
US10959631B2 (en) * 2014-02-01 2021-03-30 Biocircuit Technologies, Inc. Neural interfacing device
CN106061546A (en) * 2014-02-10 2016-10-26 Lts勒曼治疗系统股份公司 Microneedle system and method for the production thereof
EP2905047A1 (en) * 2014-02-10 2015-08-12 LTS LOHMANN Therapie-Systeme AG Micro-needle system and method for producing the same
US20170049695A1 (en) * 2014-02-27 2017-02-23 Hisamitsu Pharmaceutical Co., Inc. Microneedle sheet
US10675176B1 (en) 2014-03-19 2020-06-09 Zeltiq Aesthetics, Inc. Treatment systems, devices, and methods for cooling targeted tissue
USD777338S1 (en) 2014-03-20 2017-01-24 Zeltiq Aesthetics, Inc. Cryotherapy applicator for cooling tissue
US20160279401A1 (en) 2015-03-27 2016-09-29 Allergan, Inc. Dissolvable microneedles for skin treatment
US20170185748A1 (en) 2014-03-30 2017-06-29 Abbott Diabetes Care Inc. Method and Apparatus for Determining Meal Start and Peak Events in Analyte Monitoring Systems
US10952891B1 (en) 2014-05-13 2021-03-23 Zeltiq Aesthetics, Inc. Treatment systems with adjustable gap applicators and methods for cooling tissue
US10935174B2 (en) 2014-08-19 2021-03-02 Zeltiq Aesthetics, Inc. Stress relief couplings for cryotherapy apparatuses
US10568759B2 (en) 2014-08-19 2020-02-25 Zeltiq Aesthetics, Inc. Treatment systems, small volume applicators, and methods for treating submental tissue
ES2944885T3 (en) 2014-08-29 2023-06-26 Corium Pharma Solutions Inc Matrix of microstructures for administration of active agents
CN105455855B (en) * 2014-09-04 2018-05-25 微凸科技股份有限公司 Lactic acid measuring equipment and the method for training adjustment
US10624843B2 (en) 2014-09-04 2020-04-21 Corium, Inc. Microstructure array, methods of making, and methods of use
JP5967595B2 (en) * 2014-09-08 2016-08-10 株式会社かいわ Puncture device
WO2016039333A1 (en) * 2014-09-08 2016-03-17 株式会社かいわ Puncture device
EP4112076A1 (en) 2014-10-10 2023-01-04 The Regents of The University of Michigan Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
MA40920A (en) 2014-11-07 2017-09-12 Takeda Vaccines Inc VACCINES OF THE HAND, FOOT AND MOUTH, AND METHODS OF MANUFACTURING AND USE THEREOF
AU2015252119A1 (en) 2014-11-07 2016-05-26 Takeda Vaccines, Inc. Hand, foot, and mouth vaccines and methods of manufacture and use thereof
BR112017009805A2 (en) 2014-11-14 2017-12-26 Cytrellis Biosystems Inc devices and methods for skin ablation
JP6906885B2 (en) 2014-11-14 2021-07-21 ロレアル Microneedle sheet to reduce wrinkles
WO2016088886A1 (en) 2014-12-05 2016-06-09 久光製薬株式会社 Microneedle device system
EP3253440B1 (en) 2015-02-02 2022-12-21 Vaxxas Pty Limited Microprojection array applicator
EP3268034A4 (en) 2015-03-05 2018-11-14 Northwestern University Non-neuroinvasive viruses and uses thereof
CA2984939A1 (en) 2015-05-14 2016-11-17 Abbott Diabetes Care Inc. Compact medical device inserters and related systems and methods
US10213139B2 (en) 2015-05-14 2019-02-26 Abbott Diabetes Care Inc. Systems, devices, and methods for assembling an applicator and sensor control device
WO2017004067A1 (en) 2015-06-29 2017-01-05 Corium International, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
US11553883B2 (en) 2015-07-10 2023-01-17 Abbott Diabetes Care Inc. System, device and method of dynamic glucose profile response to physiological parameters
WO2017045031A1 (en) 2015-09-18 2017-03-23 Vaxxas Pty Limited Microprojection arrays with microprojections having large surface area profiles
WO2017070112A1 (en) 2015-10-19 2017-04-27 Zeltiq Aesthetics, Inc. Vascular treatment systems, cooling devices, and methods for cooling vascular structures
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
WO2017075086A1 (en) 2015-10-26 2017-05-04 Halo Neuro, Inc. Electrode positioning system and method
EP3399950A1 (en) 2016-01-07 2018-11-14 Zeltiq Aesthetics, Inc. Temperature-dependent adhesion between applicator and skin during cooling of tissue
WO2017123652A1 (en) 2016-01-11 2017-07-20 Verndari, Inc. Microneedle compositions and methods of using same
CA3013158A1 (en) * 2016-01-27 2017-08-03 Undercover Colors, Inc. Methods and apparatus for detecting compounds in liquids
CN108778409B (en) 2016-02-08 2022-04-08 哈洛纽罗公司 Method and system for improving provision of electrical stimulation
US10765552B2 (en) 2016-02-18 2020-09-08 Zeltiq Aesthetics, Inc. Cooling cup applicators with contoured heads and liner assemblies
US9918932B2 (en) 2016-02-19 2018-03-20 Zosano Pharma Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines
US10939912B2 (en) * 2016-03-01 2021-03-09 Kitotech Medical, Inc. Microstructure-based systems, apparatus, and methods for wound closure
JP6968867B2 (en) 2016-03-29 2021-11-17 サイトレリス バイオシステムズ,インコーポレーテッド Devices and methods for cosmetological skin resurfacing
US10555831B2 (en) 2016-05-10 2020-02-11 Zeltiq Aesthetics, Inc. Hydrogel substances and methods of cryotherapy
US10682297B2 (en) 2016-05-10 2020-06-16 Zeltiq Aesthetics, Inc. Liposomes, emulsions, and methods for cryotherapy
US11382790B2 (en) 2016-05-10 2022-07-12 Zeltiq Aesthetics, Inc. Skin freezing systems for treating acne and skin conditions
WO2017201390A1 (en) 2016-05-19 2017-11-23 The Regents Of The University Of Michigan Novel adjuvant compositions
GB201610599D0 (en) 2016-06-17 2016-08-03 Glaxosmithkline Biologicals Sa Immunogenic Composition
US10485443B2 (en) 2016-06-20 2019-11-26 Halo Neuro, Inc. Electrical interface system
US20190184366A1 (en) * 2016-08-03 2019-06-20 Verndari, Inc. Microarrays and methods
CA3037490A1 (en) 2016-09-21 2018-03-29 Cytrellis Biosystems, Inc. Devices and methods for cosmetic skin resurfacing
WO2018096396A1 (en) 2016-11-22 2018-05-31 University Of Oslo Albumin variants and uses thereof
WO2018136898A1 (en) 2017-01-23 2018-07-26 Abbott Diabetes Care Inc. Systems, devices and methods for analyte sensor insertion
US11065428B2 (en) 2017-02-17 2021-07-20 Allergan, Inc. Microneedle array with active ingredient
US10512770B2 (en) 2017-03-08 2019-12-24 Halo Neuro, Inc. System for electrical stimulation
EP3595515A4 (en) 2017-03-14 2020-12-30 University of Connecticut Biodegradable pressure sensor
WO2018175489A1 (en) 2017-03-21 2018-09-27 Abbott Diabetes Care Inc. Methods, devices and system for providing diabetic condition diagnosis and therapy
US11278217B2 (en) * 2017-03-31 2022-03-22 RichHealth Technology Corporation Transdermal microneedle array patch
EP4306803A2 (en) 2017-03-31 2024-01-17 Vaxxas Pty Limited Device and method for coating surfaces
US11076879B2 (en) 2017-04-26 2021-08-03 Zeltiq Aesthetics, Inc. Shallow surface cryotherapy applicators and related technology
EP3639010A4 (en) 2017-06-13 2021-03-17 Vaxxas Pty Limited Quality control of substrate coatings
WO2018237221A1 (en) 2017-06-23 2018-12-27 Nosocomial Vaccine Corporation Immunogenic compositions
CA3071680A1 (en) 2017-08-04 2019-02-07 Vaxxas Pty Limited Compact high mechanical energy storage and low trigger force actuator for the delivery of microprojection array patches (map)
AU2017428907B2 (en) 2017-08-23 2021-12-16 Zosano Pharma Corporation Method of rapidly achieving therapeutic concentrations of zolmitriptan for treatment of migraines and cluster headaches
US11660264B2 (en) 2017-08-23 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
US20210069319A1 (en) 2017-09-07 2021-03-11 University Of Oslo Vaccine molecules
US20220118076A1 (en) 2017-09-07 2022-04-21 University Of Oslo Vaccine molecules
US10524730B2 (en) * 2017-09-28 2020-01-07 Medtronic Minimed, Inc. Medical devices with microneedle arrays and methods for operating such medical devices
CN107874767B (en) * 2017-10-12 2020-11-24 杭州博拓生物科技股份有限公司 Device for detecting analyzed substance in sample
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
CA3077720A1 (en) 2017-10-24 2019-05-02 Dexcom, Inc. Pre-connected analyte sensors
KR20200117981A (en) 2017-11-03 2020-10-14 다케다 백신즈 인코포레이티드 Zika vaccine and immunogenic composition, and methods of using the same
JP6920179B2 (en) 2017-11-15 2021-08-18 新光電気工業株式会社 Biological electrode parts and their manufacturing methods
US10507324B2 (en) 2017-11-17 2019-12-17 Halo Neuro, Inc. System and method for individualizing modulation
GB201721576D0 (en) 2017-12-21 2018-02-07 Glaxosmithkline Biologicals Sa Hla antigens and glycoconjugates thereof
GB201721582D0 (en) 2017-12-21 2018-02-07 Glaxosmithkline Biologicals Sa S aureus antigens and immunogenic compositions
US10828500B2 (en) 2017-12-22 2020-11-10 Cardiothrive, Inc. External defibrillator
JP7305311B2 (en) 2018-05-30 2023-07-10 ロレアル microneedle sheet
CN112399908B (en) 2018-06-25 2023-04-07 考里安公司 Method of forming master mold, casting mold, and method of making microstructure array
US11660265B2 (en) 2018-06-28 2023-05-30 Emergex USA Corporation Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
JP7335061B2 (en) 2018-06-29 2023-08-29 ロレアル Beauty method using microneedle sheet
JP2020002084A (en) 2018-06-29 2020-01-09 ロレアル Cosmetic process using microneedle sheet
JP2020018327A (en) 2018-07-17 2020-02-06 ロレアル Microneedle sheet
JP2021532873A (en) 2018-07-31 2021-12-02 ゼルティック エステティックス インコーポレイテッド Methods, devices, and systems to improve skin properties
WO2020071924A1 (en) * 2018-10-04 2020-04-09 ONiO AS Sensor system with notification function and method for continuous and wireless monitoring and analysis of temperature in organisms
JP2020099513A (en) 2018-12-21 2020-07-02 ロレアル Kit and cosmetic process using microneedle sheet
US11826495B2 (en) 2019-03-01 2023-11-28 University Of Connecticut Biodegradable piezoelectric ultrasonic transducer system
USD1002852S1 (en) 2019-06-06 2023-10-24 Abbott Diabetes Care Inc. Analyte sensor device
AU2020301239A1 (en) * 2019-06-28 2022-02-03 Passport Technologies, Inc. Methods and systems for controlling energy delivery to filament devices
JP2021094146A (en) 2019-12-16 2021-06-24 ロレアル Cosmetic method using microneedle sheet
WO2021168330A1 (en) * 2020-02-19 2021-08-26 Kitotech Medical, Inc. Microstructures to attach appliances to tissues
US11745001B2 (en) 2020-03-10 2023-09-05 University Of Connecticut Therapeutic bandage
FR3113843A1 (en) 2020-09-07 2022-03-11 L'oreal KIT AND COSMETIC TREATMENT USING MICRO-NEEDLE SHEET
WO2021256214A1 (en) 2020-06-17 2021-12-23 L'oreal Kit and cosmetic process using microneedle sheet
USD999913S1 (en) 2020-12-21 2023-09-26 Abbott Diabetes Care Inc Analyte sensor inserter
WO2023039108A1 (en) 2021-09-08 2023-03-16 Affinivax, Inc. Coronavirus vaccine
FR3135206A1 (en) 2022-05-05 2023-11-10 L'oreal Cosmetic process using microneedle sheet
FR3139007A1 (en) 2022-08-23 2024-03-01 L'oreal COMPOSITION SUITABLE FOR COSMETIC TREATMENTS OF KERATINOUS SUBSTANCE

Family Cites Families (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US946837A (en) * 1908-11-05 1910-01-18 Cordelia L Common Fountain tonic-applicator.
US2619962A (en) * 1948-02-19 1952-12-02 Res Foundation Vaccination appliance
FR1133709A (en) 1955-10-17 1957-04-01 Device intended for the application of new medical treatments
US2893392A (en) * 1958-01-08 1959-07-07 American Cyanamid Co Article of manufacture for intracutaneous injections
US3072122A (en) * 1959-01-15 1963-01-08 Rosenthal Sol Roy Package for transcutaneous injection
US2974787A (en) * 1960-05-10 1961-03-14 American Cyanamid Co Single use, prepackaged vaccinator
US3322121A (en) * 1965-11-26 1967-05-30 Oscar H Banker Skin-puncturing unit with a collapsible protective cover
CH522395A (en) * 1968-07-26 1972-05-15 Micromedic Systems Inc Test tube intended for percutaneous and digital blood sampling
US3675766A (en) * 1970-02-04 1972-07-11 Sol Roy Rosenthal Multiple puncture injector device
US3964482A (en) * 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
BE795384A (en) * 1972-02-14 1973-08-13 Ici Ltd DRESSINGS
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
JPS5029096U (en) * 1973-07-06 1975-04-02
OA05448A (en) * 1975-10-16 1981-03-31 Manufrance Manufacture Francai Multi-penetrating vaccine device.
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4014334A (en) 1976-02-02 1977-03-29 Alza Corporation Laminated osmotic system for dispensing beneficial agent
US4141359A (en) 1976-08-16 1979-02-27 University Of Utah Epidermal iontophoresis device
US4127118B1 (en) * 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
GB2066376B (en) 1977-11-09 1982-10-20 Emerit Andre A C Source of vacuum and device for creating and maintaining a negative pressure in an enclosure
US4250878A (en) 1978-11-22 1981-02-17 Motion Control, Inc. Non-invasive chemical species delivery apparatus and method
US4383529A (en) * 1980-11-03 1983-05-17 Wescor, Inc. Iontophoretic electrode device, method and gel insert
US4340048A (en) 1981-03-28 1982-07-20 Alza Corporation Self-driven hypodermic injector
US5370675A (en) * 1992-08-12 1994-12-06 Vidamed, Inc. Medical probe device and method
US4753651A (en) 1982-08-30 1988-06-28 Alza Corporation Self-driven pump
USH356H (en) * 1985-02-27 1987-11-03 Medtronic, Inc. Epicardial lead having low threshold, low polarization myocardial electrode
SU1296174A1 (en) * 1985-06-20 1987-03-15 Устиновский Государственный Медицинский Институт Apparatus for electrophoresis of medicines
US4655766A (en) 1985-08-01 1987-04-07 Alza Corporation Fluid imbibing pump with self-regulating skin patch
US4756314A (en) 1985-10-28 1988-07-12 Alza Corporation Sweat collection patch
US4711247A (en) * 1986-04-18 1987-12-08 Henry Fishman Allergy testing method and apparatus
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
DE3735137A1 (en) * 1987-10-16 1989-05-03 Siemens Ag ARRANGEMENT FOR DISPENSING MEDICINES IN AN IMPLANTABLE MEDICAL DEVICE
US5362307A (en) 1989-01-24 1994-11-08 The Regents Of The University Of California Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance
WO1989006989A1 (en) * 1988-01-29 1989-08-10 The Regents Of The University Of California Iontophoretic non-invasive sampling or delivery device
US5438984A (en) 1988-09-08 1995-08-08 Sudor Partners Apparatus and method for the collection of analytes on a dermal patch
US5169382A (en) * 1988-10-03 1992-12-08 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5147296A (en) * 1988-10-03 1992-09-15 Alza Corporation Membrane for electrotransport transdermal drug delivery
US4941517A (en) * 1988-10-20 1990-07-17 Galloway Trust Aseptic fluid transfer apparatus and methods
US5054499A (en) 1989-03-27 1991-10-08 Swierczek Remi D Disposable skin perforator and blood testing device
US5139023A (en) * 1989-06-02 1992-08-18 Theratech Inc. Apparatus and method for noninvasive blood glucose monitoring
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5036861A (en) 1990-01-11 1991-08-06 Sembrowich Walter L Method and apparatus for non-invasively monitoring plasma glucose levels
US5161532A (en) 1990-04-19 1992-11-10 Teknekron Sensor Development Corporation Integral interstitial fluid sensor
US5300100A (en) * 1990-08-22 1994-04-05 Advanced Warming Systems, Inc. Body warmer
US5158537A (en) * 1990-10-29 1992-10-27 Alza Corporation Iontophoretic delivery device and method of hydrating same
US5279544A (en) * 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
US5156591A (en) 1990-12-13 1992-10-20 S. I. Scientific Innovations Ltd. Skin electrode construction and transdermal drug delivery device utilizing same
SE9101022D0 (en) 1991-01-09 1991-04-08 Paal Svedman MEDICAL SUSPENSION DEVICE
US5312456A (en) 1991-01-31 1994-05-17 Carnegie Mellon University Micromechanical barb and method for making the same
US5122114A (en) * 1991-02-01 1992-06-16 Board Of Regents, University Of Texas System Method of using intramedullary catheter
US5231993A (en) 1991-11-20 1993-08-03 Habley Medical Technology Corporation Blood sampler and component tester with guide member
JP2572823Y2 (en) 1992-02-13 1998-05-25 株式会社アドバンス Simple blood sampler
US5484399A (en) * 1992-02-27 1996-01-16 Sloan-Kettering Institute For Cancer Research Process and device to reduce interstitial fluid pressure in tissue
US5309909A (en) * 1992-05-22 1994-05-10 Physio-Control Corporation Combined skin preparation and monitoring electrode
JPH0670987A (en) 1992-08-28 1994-03-15 Katsuro Tachibana Medicine dosing and body liquid taking-out unit and device therefor
US5300110A (en) * 1992-10-15 1994-04-05 Angeion Corporation Dirk-based epicardial defibrillation electrode
JPH0824680B2 (en) 1992-10-26 1996-03-13 日本電気株式会社 Suction leachate sampling device
US5702359A (en) * 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
JP2630197B2 (en) 1993-04-28 1997-07-16 株式会社ニッショー Blood suction device
US5582184A (en) * 1993-10-13 1996-12-10 Integ Incorporated Interstitial fluid collection and constituent measurement
US5885211A (en) 1993-11-15 1999-03-23 Spectrix, Inc. Microporation of human skin for monitoring the concentration of an analyte
JPH084182A (en) * 1994-06-17 1996-01-09 Nippon Steel Metal Prod Co Ltd Anchor member for flat deck plate
CA2193885C (en) 1994-06-24 2003-11-25 Janet Tamada Iontophoretic sampling device and method
DE59505328D1 (en) * 1994-12-09 1999-04-15 Novartis Ag TRANSDERMAL SYSTEM
AU5740496A (en) * 1995-05-22 1996-12-11 General Hospital Corporation, The Micromechanical device and method for enhancing delivery of compounds through the skin
AU5869796A (en) 1995-05-22 1996-12-11 Ned A. Godshall Micromechanical patch for enhancing the delivery of compound s through the skin
US5571162A (en) * 1995-06-07 1996-11-05 Intermedics, Inc. Transvenous defibrillation lead with side hooks
DE19525607A1 (en) * 1995-07-14 1997-01-16 Boehringer Ingelheim Kg Transcorneal drug delivery system
TR199800347T1 (en) 1995-08-29 1998-05-21 Spectrx, Inc. Micro-poring of human skin for drug application and monitoring applications.
US5682233A (en) 1995-09-08 1997-10-28 Integ, Inc. Interstitial fluid sampler
US6230051B1 (en) * 1996-06-18 2001-05-08 Alza Corporation Device for enhancing transdermal agent delivery or sampling
US6183434B1 (en) 1996-07-03 2001-02-06 Spectrx, Inc. Multiple mechanical microporation of skin or mucosa
DE69718495T2 (en) * 1996-09-17 2003-11-20 Deka Products Lp SYSTEM FOR DISPOSAL OF MEDICINE BY TRANSPORT
US6918901B1 (en) * 1997-12-10 2005-07-19 Felix Theeuwes Device and method for enhancing transdermal agent flux
KR100557261B1 (en) * 1997-12-11 2006-03-07 알자 코포레이션 Device for enhancing transdermal agent flux
ATE221400T1 (en) * 1997-12-11 2002-08-15 Alza Corp DEVICE FOR INCREASE THE TRANSDERMAL FLOW OF ACTIVE INGREDIENTS
DK1037686T3 (en) * 1997-12-11 2006-01-02 Alza Corp Apparatus for enhancing transdermal flow of agents
US6022316A (en) * 1998-03-06 2000-02-08 Spectrx, Inc. Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications
US7419481B2 (en) * 2000-10-13 2008-09-02 Alza Corporation Apparatus and method for piercing skin with microprotrusions
HUP0303576A2 (en) * 2000-10-13 2004-01-28 Alza Corp Microprotrusion member retainer for impact applicator
NZ525294A (en) * 2000-10-13 2005-02-25 Alza Corp Apparatus and method for piercing skin with microprotrusions
CN100391404C (en) * 2000-10-13 2008-06-04 阿尔扎公司 Microblade array impact applicator
CA2427381A1 (en) * 2000-10-26 2002-11-28 Alza Corporation Transdermal drug delivery devices having coated microprotrusions
US6855372B2 (en) * 2001-03-16 2005-02-15 Alza Corporation Method and apparatus for coating skin piercing microprojections
DE60233939D1 (en) * 2001-04-20 2009-11-19 Alza Corp MICROPROJECTION ARRANGEMENT WITH A COATING CONTAINING ADVANTAGEOUS MEDIUM
US20030199810A1 (en) * 2001-11-30 2003-10-23 Trautman Joseph Creagan Methods and apparatuses for forming microprojection arrays
ES2297056T3 (en) * 2001-12-20 2008-05-01 Alza Corporation MICRO-PROJECTIONS FOR SKIN PERFORATION THAT HAVE CONTROL OF THE DEPTH OF DRILLING.
DE60315061T2 (en) * 2002-06-14 2007-11-22 Ogawa & Co., Ltd. INHIBITOR AGAINST TASTING AND INHIBITOR AGAINST THE PRODUCTION OF ODOR CAUSED BY CITRAL IMMUNITY
AR042815A1 (en) * 2002-12-26 2005-07-06 Alza Corp ACTIVE AGENT SUPPLY DEVICE THAT HAS COMPOUND MEMBERS
US20050123507A1 (en) * 2003-06-30 2005-06-09 Mahmoud Ameri Formulations for coated microprojections having controlled solubility
JP2007535337A (en) * 2003-10-28 2007-12-06 アルザ・コーポレーシヨン Delivery of therapeutic peptide and protein polymer conjugates by coated microprojections
AU2004287414B2 (en) * 2003-10-31 2010-11-25 Alza Corporation Self-actuating applicator for microprojection array
WO2005051456A2 (en) * 2003-11-13 2005-06-09 Alza Corporation Composition and apparatus for transdermal delivery
MXPA06013168A (en) * 2004-05-13 2007-05-15 Johnson & Johnson Apparatus and method for transdermal delivery of parathyroid hormone agents.
US20060188555A1 (en) * 2005-01-21 2006-08-24 Micheal Cormier Therapeutic peptide formulations with improved stability
TW200700094A (en) * 2005-01-31 2007-01-01 Alza Corp Coated microprojections having reduced variability and method for producing same
WO2006089285A1 (en) * 2005-02-16 2006-08-24 Alza Corporation Microprojection arrays with improved biocompatibility
US8374997B2 (en) * 2005-05-20 2013-02-12 Teradota Us, Inc. Application code generation and execution with bypass, logging, user restartability and status functionality
WO2006130868A1 (en) * 2005-06-02 2006-12-07 Alza Corporation Method for terminal sterilization of transdermal delivery devices
US20070009587A1 (en) * 2005-06-21 2007-01-11 Peter Daddona Method and device for coating a continuous strip of microprojection members

Also Published As

Publication number Publication date
JP3847790B2 (en) 2006-11-22
EP0914178B1 (en) 2003-03-12
DE69730971D1 (en) 2004-11-04
US7184826B2 (en) 2007-02-27
AU3399197A (en) 1998-01-07
ES2230611T3 (en) 2005-05-01
US20070118070A1 (en) 2007-05-24
CA2253471C (en) 2007-10-30
WO1997048440A1 (en) 1997-12-24
ATE234129T1 (en) 2003-03-15
US6230051B1 (en) 2001-05-08
JP2001507947A (en) 2001-06-19
EP0917484B1 (en) 2004-09-29
EP0917483A1 (en) 1999-05-26
ZA975326B (en) 1998-01-14
CA2257217C (en) 2006-03-07
PT917483E (en) 2005-01-31
PT917484E (en) 2004-12-31
JP2007260436A (en) 2007-10-11
ES2195151T3 (en) 2003-12-01
EP0914178A1 (en) 1999-05-12
WO1997048441A1 (en) 1997-12-24
TW349872B (en) 1999-01-11
ES2230614T3 (en) 2005-05-01
CA2253471A1 (en) 1997-12-24
EP0917483B1 (en) 2004-09-29
JP2001505444A (en) 2001-04-24
AR012859A2 (en) 2000-11-22
DE69719761D1 (en) 2003-04-17
CA2257217A1 (en) 1997-12-24
DK0914178T3 (en) 2003-04-22
WO1997048442A1 (en) 1997-12-24
JP2000512529A (en) 2000-09-26
AU3493397A (en) 1998-01-07
DE69730973D1 (en) 2004-11-04
US6219574B1 (en) 2001-04-17
DE69730971T2 (en) 2005-11-17
US20020016562A1 (en) 2002-02-07
CA2253549A1 (en) 1997-12-24
AR008242A1 (en) 1999-12-29
DE69719761T2 (en) 2003-12-18
US6537264B1 (en) 2003-03-25
AU3572597A (en) 1998-01-07
ATE277670T1 (en) 2004-10-15
EP0917484A1 (en) 1999-05-26
ATE277671T1 (en) 2004-10-15
DK0917483T3 (en) 2005-02-07
DK0917484T3 (en) 2005-02-07
JP4012252B2 (en) 2007-11-21
DE69730973T2 (en) 2005-11-17

Similar Documents

Publication Publication Date Title
CA2253549C (en) Device for enhancing transdermal agent delivery or sampling
EP0957972B1 (en) Device and method for enhancing transdermal agent flux
US6918901B1 (en) Device and method for enhancing transdermal agent flux
CA2313698C (en) Device for enhancing transdermal agent flux
EP1037687B1 (en) Device for enhancing transdermal agent flux
AU739616B2 (en) Device for enhancing transdermal agent flux
KR100500202B1 (en) Device for enhancing transdermal agent delivery or sampling
KR100500203B1 (en) Device for enhancing transdermal agent delivery or sampling
EP1911488A2 (en) Device for enhancing transdermal agent flux
MXPA00005761A (en) Device for enhancing transdermal agent flux

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed